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ABSTRACT
The experience of fatigue has been a common problem among community populations
for decades. The symptom of fatigue is also a frequent health complaint in primary care
practices. Fatigue patients have been shown to be significantly high users of health care
resources, particularly when compared to non-fatigued patient populations. To date, an
understanding of the presence and the impact of the symptom of fatigue within the context of the
Canadian health care system has been understudied.
The objective of this research was to determine the number of patients who were suffering
from the symptom of fatigue within a primary care setting and to explore the determinants of
their health care utilization patterns. Furthermore, these patterns of health care use were
compared to a non-fatigue symptom patient population, who were also from a primary care setting.
The data were extracted from a longitudinal electronic medical record database, which captures
details of primary care encounters throughout Southwestern Ontario.
The fatigue symptom patients were found to experience a large complex of co-occurring
morbidity and a markedly high level of referral following their visit with the symptom of fatigue.
As well, the fatigue symptom patients were found to have an increased number of subsequent
visits to their primary care provider and an increased number of investigations during a one year
follow-up period, when compared to the non-fatigue symptom group.
These findings begin to create an understanding of fatigue symptom patients, their
complex of morbidity, and their subsequent health care use patterns. This information will help
to improve the management of fatigue symptom patients in Canadian primary care practices and
in the Canadian health care system more broadly.

KEYWORDS: Fatigue, Primary Care, Prevalence, Health Care Utilization
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CHAPTER ONE – INTRODUCTION
The first chapter of this thesis will give a brief introduction to the magnitude,
measurement and management of the symptom of fatigue. This will begin to establish the
background and contextual basis for the main focus of this research, which are the health care
utilization patterns of fatigue symptom patients in primary care.

1.1. An Introduction to the Problem of Fatigue
Symptoms of ill health are a common part of daily life for most people 1, 2. More
specifically, the symptom of fatigue is a common experience in general populations throughout
the developed world. Community-based surveys conducted in the United States and in Europe
have indicated that as many as 50% of community populations reported experiencing fatigue if
asked 3, 4, and national population surveys have estimated that 20% to 30% of adults reported
experiencing significant fatigue at any given time 3, 5. However, the prevalence of the symptom
of fatigue among the Canadian population continues to be unknown and understudied. The
Statistics Canada 2005 Canadian Community Health Survey, which is a cross-sectional survey
that covers approximately 98% of the Canadian population aged twelve years of age and older,
found that almost a million Canadians, predominantly female and middle-aged, have received a
diagnosis of chronic fatigue syndrome (CFS) or fibromyalgia 6. This is likely a substantial
underrepresentation of the prevalence of fatigue symptoms among Canadians, as a small
minority (5% to 10%) of individuals who experience fatigue actually receive a diagnosis of CFS
or fibromyalgia from their health care provider 7, 8. Fatigue symptoms have been found to be
present in at least 20% of patients who visit a primary care provider each year 9. Not only is
fatigue a common complaint in community and primary care settings, but it also represents a
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multifaceted and trying issue for many individuals. Previous literature has highlighted the
importance of epidemiological research as a resource for understanding this multidimensional
problem.

1.2. The Measurement of Fatigue
In health care, fatigue can be interpreted, presented, and measured in a number of ways,
including as a subjective symptom, a physiological measurement, or as a chronic syndrome.
Firstly, fatigue can be defined as a subjective self-reported feeling; this is what people generally
report when they seek medical treatment 8, 10. Fatigue can be described by an individual as
feeling tired, being exhausted, feeling weak in a specific part of the body, lacking energy or
experiencing “everything as an effort” 11. However, these experiences are often difficult to
quantify or objectively measure for health care professionals. Secondly, physiological
measurements of fatigue can be achieved through objective observations of muscle
performance 12 or the time-dependent decrease in the ability to perform physical coordination or
mental tasks 13. Finally, many studies in the existing fatigue literature have focused on the
subgroup of patients who have received the diagnosis of chronic fatigue syndrome. CFS is a
distinct clinical entity from idiopathic fatigue in that it is characterized by fatigue that persists for
longer than six months (therefore is classified as chronic fatigue) and that is also associated with
impaired memory or concentration, sore throat, tender lymph nodes, headaches, non-restorative
sleep, and postexertional malaise 14. Another condition that tends to be related to fatigue
presentation is fibromyalgia. This condition presents with fatigue that is associated with chronic
pain and stiffness of the body, particularly the neck, shoulders, low back, and hips 14. The current
study will include patients who have presented to their primary care provider with a wide range
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of fatigue experiences, encompassing the entire spectrum of fatigue. As stated by Lewis &
Wessely (1992), fatigue is best viewed on a continuum 15.

1.3. The Management of the Adult Patient with Fatigue
Epidemiological and clinical studies of fatigue have concluded that this symptom is often
associated with significant morbidity 15. This makes the investigation and management of the
fatigue presentation a particular challenge for primary care providers. Fatigue is known as a
nonspecific symptom because it can be indicative of many underlying causes or related
conditions, including physiological states (such as sleep deprivation or excessive activity),
medical conditions (such as chronic inflammatory disease or blood conditions, viral infections or
autoimmune illnesses), psychiatric disorders (such as depression, anxiety states or somatoform
disorders), medication-related effects (such as from drugs prescribed for insomnia,
antihistamines or chemotherapy drugs), and unhealthy lifestyles or stressors (such as disruptions
in sleep cycles, excessive alcohol or caffeine intake, or the effects of traumatic events) 8, 16, 17.
However, regardless of the cause, every patient suffering from fatigue merits the need for a
careful assessment and evaluation.
The first part of the assessment of a fatigue patient for a health care provider is listening
to the patient's account of the symptoms, trying to understand their meaning for the patient, and
determining possible cues of their cause through a comprehensive history taking and physical
and psychological examination 16. More specifically, it is important for the primary care provider
to explore what the patient means by the fatigue or tiredness, and if possible, whether their
fatigue is associated with physical or psychological factors. Informed by the initial observations,
the provider may proceed with further investigation, if deemed necessary. As stated by
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McWhinney and Freeman (2009), clinical investigation over the course of one or two visits
should help to inform a probable diagnosis or management plan for the large majority of
patients 16. A battery of focused laboratory tests can be done to rule out common underlying
conditions or causes (such as iron deficiency or pregnancy). Standard laboratory tests often
include a complete blood count, the measurement of blood glucose levels, the measurement of
specific enzymes, antibodies or proteins in the blood, and a urinalysis. Further directed tests
(such as HIV antibody testing) or imaging tests (such as an ultrasound) may be indicated based
on the patient’s history and physical findings. Specialist assessment of the patient may also be
required if a co-occurring condition is more effectively managed or treated in a secondary or
tertiary care setting (for example, referral to an allergist if the patient presents with severe
seasonal allergies, in addition to the fatigue symptoms). Although focused investigations and
referral to specialists can constitute reasonable management for some fatigue symptom patients,
some patients may require ongoing in-office primary care visits, particularly if no medical
explanation can be found, if the symptoms of fatigue persist or worsen, or if the associated
morbidities worsen. When used properly, additional primary care visits allow for further
investigation of the patient’s complaints, and they can also help to establish a stronger patientprovider relationship, which is essential for providing support to the patient and for ensuring
health care resources are used properly and efficiently 7.
While symptoms of ill health are a common experience of everyday life for many
individuals, symptoms of fatigue have been consistently demonstrated in previous research to be
a significant burden for communities, primary care attenders and the health care system more
broadly. Fatigue has been associated with high levels of morbidity and disability, and
consequently, increased levels of health care utilization. Although few presenting complaints are
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more challenging, a broad contextual approach involving communication with the patient and
assessment of physical or psychological indicators is most effectively provided by a primary care
provider 9. As stated by Lewis and Wessely (1992), “fatigue does not kill but it is common,
disabling, and is regarded as a serious symptom by patients” 15. Therefore, evaluating fatigue
symptom patients’ health care utilization, both in the context of other symptom patients and in
the Canadian health care system, will be an important contribution to the existing literature and
will be the focus of the thesis discussed herein.
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CHAPTER TWO – LITERATURE REVIEW
This literature review was conducted in order to illustrate the problem of fatigue in
multiple contexts and dimensions, to describe previous literature examining health care
utilization among fatigue symptom patients, to identify a conceptual framework of health care
utilization, to highlight notable gaps in the literature, and finally to determine possible
contributions a study using electronic medical record (EMR) data could make to the existing
literature. Consequently, this chapter will orient the reader to the current knowledge of fatigue
symptom patients and its remaining limitations.

Section One: Description of Fatigue Patients
2.1. The Magnitude of Fatigue: The Prevalence of Fatigue and Its Associated Costs
Fatigue consistently ranks among the most commonly presented complaints to
physicians, regardless of practice setting or culture 9. The problem of excessive or unexplained
fatigue has been common both in the primary care population and the community population for
decades 18, 19. The prevalence of fatigue symptoms presented to family physicians has been found
to range from 7% to 45%, depending upon the definition of fatigue, how the fatigue symptoms
were identified and measured (for example, through primary care encounters, surveys or
measurement scales), the population studied (for example, a primary care or community
population), the inclusion and exclusion criteria applied (for example, requiring a minimum
duration of fatigue symptoms), and the setting in which the study was conducted 3, 7, 15, 20-24.
In the United States, it has been reported that fatigue was responsible for at least 10
million office visits and up to $300 million in health costs each year 25. Furthermore, although
chronic fatigue syndrome patients account for a small minority of fatigue sufferers 7, 8, the
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estimated direct and indirect costs to the community for each individual suffering from CFS has
been projected to be as high as $9,436 per patient annually 26. In a more recent study examining
the effect of chronic fatigue syndrome in the United States, the annual direct costs from CFS
were $3,286 per patient (mainly as a result of increased physician visits and prescription
medication use) and the annual loss of household earnings due to CFS were $8,554 per patient,
even after adjustment for confounding factors 27. A similar cost analysis determining the impact
of fatigue patients or chronic fatigue syndrome patients on the Canadian health care system has
not yet been completed, but it could be assured that a similar financial burden of fatigue is
present within the Canadian context as well.

2.2. The Problem of Fatigue: The Amorphous Symptom
Fatigue has been particularly problematic for family physicians or primary care providers
because of the fact that this symptom is often a nonspecific indicator of underlying medical
pathology and psychological distress 7. Furthermore, many chronically fatigued patients have
defied diagnostic categorization, including not meeting the clinical diagnosis of chronic fatigue
syndrome 8, 9. In fact, the underlying cause cannot be identified in one-third of primary care
patients presenting with fatigue, which has led to frustration for both the patient and the
provider 17. Regardless of the cause, patients typically report having a lack of energy, being
listless, and being too tired to participate in family, work, or leisure activities. The subjective
feeling of fatigue is usually what individuals reported when seeking medical treatment 8, 10.
However, this self-reported feeling of fatigue does not always correspond correctly with attempts
to measure or quantify the patient’s fatigue experiences by the provider 10. This discrepancy
between subjective presentation and attempts to objectively measure fatigue could have had an
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influence on the predominant dismissal of fatigue symptoms in general practice, as well as the
subsequent dissatisfaction patients felt with the care they had received 28, 29. Consequently, this
common, yet amorphous symptom requires a committed, informed, organized, and efficient
evaluation and assessment by health care providers in order to achieve positive outcomes 9.
Symptom research is an important but difficult field of study within the broader context
of health services research 30-32. Previous work by Kroenke identified three different methods for
eliciting symptoms from a population: chart review; survey or questionnaire administration; and
spontaneous reporting by the patient 31. Although subjectively described and voluntarily
presented problems can be influenced by both personal and health system factors that can be
difficult to account for, a comprehensive objective measure of the symptom of fatigue has been
viewed as “an unattainable Holy Grail” 33. Again, this is because the unique experience of
symptoms of illness does not easily translate into one comprehensive objective measure 1. Efforts
to create a valid and reliable measurement tool for fatigue symptoms have produced scales such
as the Fatigue Scale 34 and the Fatigue Severity Scale 35. However, there continues to be a lack of
consistency within previous fatigue research in the way that “case” patients are identified and
subsequently evaluated. As a result, symptom reporting by patients is considered to be the most
relevant method of case identification for clinical practice 31 and this method was utilized within
the present study.

2.3. Characteristics of Patients with Fatigue: Demographics, Morbidity, and Duration
Studies of fatigue patients have shown a bimodal distribution of patient age, with a peak
in young adults aged 18 to 24 years and a second peak in older adults aged 60 years and over 9, 23,
36, 37

. Many studies have examined the role of gender in fatigue presentation. Some researchers
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have found that women were more than twice as likely to seek medical help for their fatigue
symptoms as compared to men 4, 11, 36, 38. Although this excess might have been explained
exclusively by a higher incidence of fatigue in women as compared to men, it may have also
been a result of a number of other underlying factors, including: that women were more frequent
attenders to their family physician, giving them a greater opportunity to present symptoms; that
women were more likely to express that they were feeling fatigued when visiting their family
physician; or possibly that physicians were more sensitive to the ways in which women complain
about fatigue symptoms 9. While many studies have found similar gender differences, with
women being more likely to report both fatigue and chronic fatigue symptoms 3, 5, 28, 32, some
primary care and hospital-based studies have found no statistically significant gender differences
in fatigue presentation 25, 39. Furthermore, the relationship between patient ethnicity and fatigue
presentation or prognosis has not been clearly defined in previous literature 40-42.
Fatigue has been an important symptom in primary care practices due to its particularly
high association with psychological and social problems. Reports using structured diagnostic
assessments have revealed that between 50% and 80% of patients complaining of persistent and
disabling fatigue in various clinical settings (including primary, secondary, and tertiary care
clinics) met criteria for a psychiatric disorder, most commonly major depression, anxiety states,
and somatization disorder 4, 8, 16, 43-45. The temporality of the fatigue presentation and the
psychiatric disorder may be difficult to ascertain in individual cases 43. Studies have examined
the timing of fatigue and psychiatric symptoms and have shown that the psychological or
psychosocial symptoms frequently occurred either before or at the same time as the onset of the
chronic fatigue, therefore indicating that the psychosocial symptoms were either a cause of or
were co-occurring with the fatigue symptoms 3, 4, 46, 47.
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Patients presenting with the symptom of fatigue have also been shown to experience high
levels of co-occurring chronic morbidity 3, 8, 15, 43, 48. In a study by Kroenke et al. (1988), the
prevalence of chronic morbidity was significantly higher among patients presenting with fatigue
in comparison to other non-fatigued patients 3. In fact, fatigue symptom patients have been found
to have an average co-morbidity count of 16.6 conditions over a four year period, which was
significantly higher than the average co-morbidity count of 10.4 conditions experienced by the
general patient population over the same four year period 23.
Despite the recognition that fatigue symptoms can be an entangled and integrated
component of chronic disease, its etiology in many chronic illnesses continues to not be well
understood 8, 39, 48. Within this subset of fatigue symptom patients, the ability of health care
providers to address a lengthy and broad differential diagnosis, while establishing the placement
of the fatigue symptoms in the context of chronic and psychosocial morbidity, both in
partnership with the patient and as efficiently as possible, was considered a significant task in
primary care practice 9.
When presented in primary care, providers tend to focus on co-occurring symptoms
and to adhere to a wait-and-see policy for patients experiencing symptoms of fatigue 49.
However, examining the duration and prognosis of the fatigue has been shown to better predict
the course of fatigue and to more effectively manage future health care use 49, 50. A study
conducted in the United States determined that of patients who reported fatigue as a major
problem to their primary care providers, the mean duration of the fatigue was 3.3 years 3. In
terms of prognosis, a systematic review conducted by Nijrolder et al. (2008) found that among
previous studies conducted in the primary care setting, recovery or improvement in fatigue
symptoms ranged from 22% to 97% of fatigue patients 49.
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A Canadian study by Cathebras et al. (1992) examined 93 adult patients who attended
their primary care provider through a self-initiated visit for a new symptom of fatigue and found
that the outcome of fatigue was generally poor. This study estimated that between one half to
two thirds of their fatigue patients continued to have fatigue complaints one year following the
primary care visit; a longer duration of fatigue symptoms prior to the primary care visit predicted
worse outcomes and longer times to recovery 39. A study conducted in the United States by
Valdini et al. (1988) determined that 58% of family practice patients who presented with a chief
complaint of fatigue were still fatigued one year after the initial visit 51. Ridsdale et al. (1993)
identified 220 British patients who presented to their general practitioner with a chief complaint
of fatigue 38. This study found that 59% of patients were still fatigued after 6 months. Patients
with a previous diagnosis of anxiety or depression (OR=3.0, 95% CI=1.4 - 6.1) and those with
fatigue symptom duration lasting more than three months prior to the visit (OR=2.1, 95% CI=1.1
- 4.1) were more likely to remain fatigued at follow-up 38. These results were supported by an
extensive international study involving fifteen primary care centers located in fourteen countries,
in which both psychological morbidity and duration of fatigue symptoms predicted persistence of
fatigue at follow-up 52.The previously noted study completed by Kroenke et al. (1988) 3 failed to
demonstrate a similar effect of these variables on prognosis, while Taylor et al. (2002) 53
concluded that the severity of fatigue at baseline was the most significant predictor of persistent
fatigue symptoms at follow-up.

2.4. Summary of Existing Literature on Fatigue Symptom Patients
In summary, the symptom of fatigue was highly prevalent in both community and
primary care settings. With the exception of Cathebras et al.’s study conducted in 1992, the
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majority of key findings regarding fatigue symptom patients have been derived from studies that
have been based in the United States or in Europe. In general, these studies have found that the
symptom of fatigue was experienced by a diverse demographic of primary care patients and that
fatigue was often enmeshed in a complex of co-occurring symptoms and chronic morbidities.
The presentation of fatigue by patients in primary care, as well as the duration and prognosis of
this symptom, tended to be highly correlated with the presence of psychological and
psychosocial morbidities. Although these studies have concluded that fatigue symptom patients
represented a very complex and significant issue in primary care settings, a stronger
understanding of the prevalence and level of morbidity of these patients within the Canadian
primary care setting is still required.

Section Two: Description of Health Care Utilization
2.5. Theory of Health Care Utilization
Many theories have been applied to health care seeking behaviours to explain why
individuals and populations used health care services and health care resources. For example,
attachment theory, which proposed that early childhood experiences with family caregivers
shaped an individual’s behaviours within their interpersonal relationships, has been used to
understand health service utilization 54. Specifically, individuals who have developed certain
types of insecure attachment styles were more likely to report physical symptoms and to visit a
primary care provider 54. Alternatively, the social cognitive theory has been used to describe a
multifaceted causal structure of an individual’s health care use involving self-efficacy,
behavioural acquisition (through learning and reinforcements), outcome expectations, and
perceived environmental or social impediments and facilitators 55, 56.
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However, Andersen’s behavioural model of health services use 57-59, initially developed
over 35 years ago, has been one of the most frequently used frameworks for conceptually
organizing factors that might influence health care utilization behaviours. This conceptual
framework worked to account for three main determinants of health service utilization: 1)
individual behavior; 2) societal characteristics; and 3) health system factors. The individual
behavior was composed of both predisposing and needs-based factors, which are described in
more detail below. Societal characteristics were comprised mainly of the technology (for
example, the development of immunizations and the use of anesthesia) developed and used in
health care delivery and the associated societal norms of receiving this care 58. The health system
factors represented determinants affecting the provision of formal health care goods and services
in society. These factors involved the structural and resource-based elements of the health care
system, including the organization of the system (for example, how medical personnel and
facilities were coordinated and controlled) and the volume of services offered by this system (for
example, the volume of services or resources offered in relation to the population being served
and the geographical distribution of these services or resources) 58.
Individual characteristics, such as age and sex, have been hypothesized to influence an
individual’s predisposed nature or propensity to use health services more than other individuals,
even though a direct causal relationship between these characteristics and subsequent health care
use has not been established 57, 58. Instead, individuals in different age groups have been shown
to experience varying levels and severities of illness and morbidity, and consequently different
patterns of medical care. The tendency of an individual to seek care could also be impacted or
influenced by the social status of the individual, which may subsequently influence an
individual’s lifestyle patterns; the health of their surrounding environment (both social and
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physical environments); and their attitudes or beliefs about health, medical care, and health care
providers 57, 58. The social status of the individual also influences the availability of appropriate
resources and associated enabling factors. These enabling factors include an individual’s
income, the level of health insurance coverage (an issue for some countries more than others),
and the accessibility to health care facilities and health care professionals 57, 58.
Finally, the level of perceived (from the individual’s or patient’s perspective) and
evaluated (from the health care provider’s perspective) illness influence an individual’s need to
access health care services and how the provider facilitates the patient’s movement through the
health system 57, 58. While the individual’s perceived illness results in the initial health care visit
with a complaint or health issue; secondary use of health services is then controlled, to a large
extent, by the health care provider who evaluates the illness and the need for further care. This
evaluated need may warrant the need for further investigation (such as through laboratory
tests or imaging tests), referral to another physician or specialist, or a follow-up visit. Although
these decisions for secondary care may be largely due to clinical judgment, the provider may
also be influenced by a constellation of other factors, including health system factors (for
example, the availability of investigative resources or the availability of specialists in the area)
and pressures that are applied by the patient (for example, to provide further investigation or to
reach a diagnosis).
To summarize, regardless of the conceptual framework used (whether Andersen’s model
or another), there are many factors that influence both the initial health care-seeking
behaviours of individuals and the subsequent health care use following the assessment of the
symptoms or complaints by the health care provider. Some of these factors may be captured and
studied through secondary analyses of electronic medical record (EMR) data, whereas some may
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only be adequately measured through primary data collection approaches. In order to develop a
suitable conceptual framework for the current study, the Andersen model of health care
utilization was adapted to structure the variables that were: 1) important factors or characteristics
associated with health care utilization; and 2) accessible and available within the EMR database.
This adapted conceptual framework is described further in Section 3.2.

2.6. The Use of Health Care Services by Fatigue Symptom Patients
Symptoms are the leading reason why patients seek medical care and often serve as a
basis for establishing a preliminary diagnosis 2, 30, 60. Patients’ self-report of symptoms in primary
care also help to guide management and treatment plans as they serve as an important indicator
of the severity and complexity of the patient’s disability and morbidity 2, 61. Patients suffering
from a complex of symptoms have been shown to be more frequent attenders of primary care
practices, and have also been shown to experience high levels of secondary and tertiary health
care use 21, 62, 63. In other words, symptom patients account for a major proportion of health
resource utilization, regardless of the particular symptom or the medical setting 63-65. This effect
has been shown to be exacerbated when the co-occurring morbidities were chronic or
psychosocial in nature 62, 66.
Fatigue patients have been shown to experience many of the characteristics that
contribute to higher health care utilization patterns, including increased age 8, 43, being female 8,
23, 28, 43

, having high levels of disability and morbidity 24, 28, 39, 49, 67, and experiencing high levels

of co-occurring psychosocial and chronic morbidity 4, 8, 39, 43. In fact, these characteristics have
also contributed to poor prognosis among fatigue symptom patients, leading to further increase in
the use of health care services. However, the degree to which a fatigue patients utilized health
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care services was not positively related to their patient satisfaction level 29. Instead, a higher use
of health care services, particularly in the absence of any final conclusions or clear management
decisions, has led to frustration and discontent from the patient and the provider alike 29.
In the Canadian study by Cathebras et al. (1992), fatigue symptom patients were found
not to be significantly different in their amount of health care use in the year preceding or
following the initial fatigue visit date, as compared to non-fatigued patients 39. More specifically,
patients with complaints of fatigue did not differ from other clinic patients in the number of visits
to the primary care clinic during the follow-up year, and were also no more likely to have been
hospitalized 39. In the one year following the initial fatigue visit, the fatigue patients attended
their primary care clinic an average of 3.4 times 39. In contrast, a study based in the United
Kingdom by Ridsdale et al. (1994) found that patients who consulted to their primary care
provider with a symptom of fatigue or tiredness (with a duration lasting for more than two
weeks) visited their health care provider significantly more frequently in the six months before
and the six months after the initial visit, as compared to the age-sex matched group of nonfatigue patients 68. In the six month period following the initial encounter, patients with fatigue
consulted to their primary care provider an average of 4.2 times (95% CI=3.7 - 4.6), as compared
with an average of 1.6 visits (95% CI=1.3 - 1.9) made by the comparison group patients 68.
In a study conducted by Kenter et al. (2003) 23 among Dutch primary care attenders, an
episode of care was constructed for patients who presented to their primary care provider with
the symptom of fatigue using the Reason for Encounter (RFE) and the International
Classification of Primary Care (ICPC) system. While the majority (72%) of patients with an
episode of care for fatigue required only one encounter with their family physician during an
average episode length of approximately six months; it was noted that this did not imply that the

17
fatigue symptoms had disappeared, or even decreased 23. The main interventions administered to
these patients during the episode of care were blood tests (75.7% of episodes), physical
examinations (49.5% of episodes), advice or health education (34.2% of episodes), and a small
number of referrals to specialists (3.3% of episodes) 23.
A study conducted by Bombardier and Buchwald (1996) found that health care use
among fatigue patients was “substantial” and that care was obtained from a wide range of allied
and alternative health professionals 24. Among fatigue patients, the most common alternative
health professionals seen were a psychiatrist, psychologist or counselor (50.9% of patients); a
naturopath or homeopath (36.2% of patients); a chiropractor (22.7% of patients); and an
acupuncturist (11.1% of patients) 24. In contrast to the findings of the Kenter et al. study, which
found a small number of visits by fatigue patients, this sample of fatigue patients had an average
of 21 health care visits during the previous year 24. Although these results were substantially
different than the Kenter et al. study, the variation in health care use may have been largely due
to the methodological differences between the two studies, which included differences in:
settings (as the Kenter et al. study took place in a Dutch family practice and the Bombardier and
Buchwald study took place in an American university-based chronic fatigue clinic); the case mix
and inclusion criteria of the patients (as the Kenter et al. study included patients presenting to
their primary care clinic with the symptom of fatigue and the Bombardier and Buchwald study
included patients who were referred to the tertiary clinic for fatigue-specific problems); and the
types of health care use that were included (as the Kenter et al. study had two broad categories of
physician visits and “specialist referrals”, whereas the Bombardier and Buchwald study collected
information on a wide range of visits to allopathic and “alternative” practitioners). Consequently,
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the previous literature showed a considerable amount of variation and lack of consensus
regarding the health care utilization patterns of fatigue symptom patients.

2.7. Summary of Existing Literature on Fatigue Symptom Patients’ Health Care Utilization
In summary, the existing literature has been effective at exploring a variety of
determinants that have influenced health care utilization by symptom patients, and more
specifically, fatigue symptom patients. These studies were particularly focused on the
predisposing (for example, the patient’s age and sex) and needs-based (for example, the patient’s
level of morbidity) individual determinants, which are important components within
Andersen’s behavioural model of health services use. These studies, which were primarily
conducted in the United States and in Europe, tended to find that symptom patients (fatigue
symptoms or otherwise) with a complex of chronic and psychosocial morbidities and who were
more frequent attenders initially, experienced a higher level of subsequent health care use during
a defined follow-up period. Furthermore, some studies demonstrated that fatigue symptom
patients in particular experienced a higher level of health care use in comparison to the average
or typical primary care population. However, a small number of these studies utilized EMR data
to explore the relationships between symptom presentation and health care use 23, 68. Only one
previous study was conducted in the Canadian primary care context, which found a considerable
amount of health care use among fatigue patients; suggesting that further study of these patients
would be important 39. As a result, a more detailed understanding of the various factors that
influence health care use among fatigue symptom patients, both as compared to other symptom
patients and in the context of the Canadian health care system, is required.
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2.8. Existing Gaps in the Literature and the Proposed Contribution of the Current Study
Symptoms of fatigue are widespread among both community and primary care
populations. Although the amorphous and multidimensional nature of fatigue symptoms can
make identification and definition of fatigue cases difficult, there is a need to more fully
understand the current prevalence of this condition in patient populations and its impact on the
health care system. Fatigue symptoms are in themselves an important cause of morbidity and
may be the manifestation of underlying physical or psychosocial distress, but they have also been
shown to create a significant financial burden on patients, communities, and on the health care
system more broadly. Primary care providers are particularly well placed to effectively manage
the primary and secondary complaints of fatigue symptom patients, in order to reduce potential
negative health outcomes and potential inefficient use of health care resources. In fact, a primary
care perspective has been highlighted as contributing important research regarding the nature,
causes and consequences of fatigue 21. As an extension of this, electronic medical record
databases have been recognized as representing a unique source of data for answering questions
about primary health care delivery 69. Establishing a greater understanding of fatigue symptom
patients in Canadian primary care settings will provide a necessary insight into these patients, an
insight that is currently lacking in existing literature. Therefore, the current study aims to utilize
a primary care EMR database to describe the characteristics of patients who present to their
primary care provider with the symptom of fatigue, as well as their subsequent use of health care
resources, all within a Canadian primary care context.
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CHAPTER THREE – METHODOLOGY
3.1. Research Objectives
1) To describe the characteristics of patients who experience an index visit for a symptom of
fatigue.
Question 1:

What are the age and sex characteristics of this symptom group?

Question 2:

What are the previous care-seeking frequencies prior to the index visit for
this symptom group?

Question 3:

What are the mean number and most frequent types of previous and cooccurring morbidities for this symptom group?

Question 4:

What is the mean number of subsequent visits experienced by this
symptom group during a one year follow-up period?

Question 5:

a) What is the mean number of referrals experienced by this symptom
group during a one year follow-up period?
b) What are the top five referrals made for this symptom group during a
one year follow-up period?

Question 6:

What is the mean number of investigations experienced by this symptom
group during a one year follow-up period?

2) To analyze the relationship between factors (covariates such as age, sex, type of previous
and co-occurring morbidity and previous care-seeking frequency) and the number of
subsequent visits, the number of referrals received, and the number of investigations
administered during a one year follow-up period.
Hypothesis 1: Patients who present with a symptom of fatigue and who have multiple
chronic or psychosocial previous and co-occurring conditions will
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experience a higher rate of health care utilization compared to patients
who present with a symptom of fatigue and who have fewer or no chronic
or psychosocial previous and co-occurring conditions, adjusting for all
other variables.
Hypothesis 2: Patients who present with a symptom of fatigue and who have a higher
previous care-seeking frequency will experience a higher rate of health
care utilization compared to patients who present with a symptom of
fatigue and who have a lower previous care-seeking, adjusting for all
other variables.

3) To analyze the differences in health care utilization patterns between patients who have
an index visit for a symptom of fatigue compared to a matched comparison group of
patients from the general patient population who have experienced an index visit for
another symptom or complaint.
Hypothesis 1: Patients who present with an index visit for fatigue will experience a
higher level of health care utilization in comparison to their matched, nonfatigue comparison patient who has experienced an index visit for another
symptom.

3.2. Thesis Framework
Considering the potential determinants of health care use that have been identified in the
previous literature, and considering what variables were accessible for the current study, an
adapted Andersen behavioural model of health services use 57, 58 was created and can be found
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in Figure 1. The patient-level variables were grouped into two categories: predisposing and needbased determinants. Predisposing factors reflected a propensity toward use of health care
services by the individual before the onset of the symptom or condition of interest; and needbased factors reflect both the actual and the perceived level of illness. The patient-level
predisposing factors included age and sex; while the need-based factors included the presence of
a symptom, the number of previous or co-occurring morbidities and the number of previous
visits experienced by the patient. Overarching context determinants were also included in the
adapted model, in order to account for the provider- and practice-level characteristics that have
been shown in the literature to influence health care utilization 70-72. Because examining the
effects of these variables on health care utilization was not an objective of the current study, the
provider number and practice number were captured using dummy variables and were controlled
for in our analyses.
The final component of the adapted Andersen model was the use of health services
outcome variables. The three dependent variables that were derived to capture health care
utilization were the number of subsequent visits experienced by the patient, the number and type
of referrals requested, and the number of investigations ordered by the primary care provider, all
in the structure of a one year follow-up period.
The objective of this research was to explore multiple predictors of health care utilization
among patients who have presented to their primary care provider with the symptom of fatigue,
and to compare these health care utilization patterns with an “average” or “typical” symptom
patient. Consequently, a case-comparison study was conducted, with the unit of analysis being
the patient (both of these study design elements will be described in later sections).
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Figure 1: Adapted Andersen’s Behavioural Model of Health Services Use*
Patient-Level Variables
Predisposing Characteristics
• Age
• Sex
Context
• Primary Care Practice
• Primary Care Provider

•
•
•
•
•

Need-Based Characteristics
Presence of Symptoms
Previous and Co-Occurring Chronic
Morbidity
Previous and Co-Occurring
Psychosocial Morbidity
Previous and Co-Occurring Other
Morbidity
Previous Care-Seeking Frequency

Use of Health Services
• Number of Subsequent
Visits
• Number and Type of
Referrals
• Number of Laboratory
Tests and Investigations

*Adapted From: Andersen RM. Revisiting the behavioural model and access to medical care:
Does it matter? Journal of Health and Social Behaviour 1995; 36: 1-10.
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3.3. Data Sources
The data for the current study were derived from two main, interrelated sources: the
Deliver Primary Health Care Information Project database and the embedded International
Classification of Primary Care patient population.

3.3.1. The Deliver Primary Health Care Information (DELPHI) Project
The Deliver Primary Health Care Information (DELPHI) Project is an on-going and
unique research database that was established in 2003 and is based at the Centre for Studies in
Family Medicine at The University of Western Ontario. With funding from the Canada Foundation
for Innovation and Ontario Primary Health Care Transition Fund grants, the DELPHI Project
was developed to create a researchable database from the electronic medical records of primary
care providers throughout Southwestern Ontario 69. This initiative recognized the potential of
EMR technology as a tool for improving practice, policy and research in primary health care.
The DELPHI Project subsequently had the central goals of facilitating the development of an
EMR system in order to improve information-sharing in an interdisciplinary primary health care
setting and to describe, assess and improve the quality of primary health care delivery 69. This
project was supported by a number of key functioning partnerships, such as with the Institute for
Clinical Evaluative Sciences (ICES), Healthscreen Solutions Inc. (the EMR software company)
and the Department of Epidemiology and Biostatistics at The University of Western Ontario.
Another key aspect of the successful execution and sustainability of this project was the
implementation process, which progressed through four integral stages: provider recruitment;
adequate EMR software uptake; well-designed database creation; and continuous data quality
assessment 69.
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Family physicians and other allied health professionals were recruited from ten family
practices throughout Southwestern Ontario. The process of recruitment was done through
complementary approaches, which included enlisting key community leaders in family medicine
to identify a suitable EMR software, soliciting interest from the Family Medicine Education and
Research Network e-mail discussion group, identifying providers who had expressed interest in
integrating an EMR software into their practice, and ensuring that the principal investigator of
the project personally visited these interested providers at their primary care practices to discuss
the details and objectives of the DELPHI Project 69. Although this strategy did not result in a
strict random sampling of primary care providers who practiced in Southwestern Ontario, the
distribution of the family physicians covered a wide geographic area of Southwestern Ontario
and was broadly representative by age and gender of Ontario family physicians. However, the
DELPHI sample was less urban than the larger Ontario family physician population 69. Of the
twenty-five family physicians that were recruited, sixteen were male and nine were female, with
a mean estimated age of 52.5 years (calculated this proxy for age using the year of graduation
and the assumption that most graduates would be on average 28 years old at the time of
graduation).
Once the DELPHI team obtained signed consent from the providers indicating their
willingness to participate in the project, the patients of each recruited practice were informed of
the project through prominently placed posters in the practices’ waiting and examining rooms 69.
Patients who did not wish to participate were invited to discuss with their primary care provider
directly or to contact the named project coordinator in order to be excluded from the data
collection. Ethics review and approval was obtained from the Ethics Review Board of the
University of Western Ontario (Study Number 11151E). As well, privacy concerns were actively
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resolved in partnership with the Office of the Information and Privacy Commissioner of
Ontario 69.
The collaboration with the EMR software company, Healthscreen Solutions Inc., allowed
the DELPHI database to accommodate research-oriented data input technologies and data
extraction possibilities 69. In order to enhance correct use of the EMR, remote training was
offered by the software vendor, supplemented by one-on-one intensive training sessions offered
by the DELPHI staff. This included customized site-specific training and continuous troubleshooting throughout the implementation process 69. Not only was this approach important in
developing a supportive relationship between the DELPHI team and the participants, but this
training was also aimed to increase the validity of the data. As almost half of the participants
were novice users of an EMR system at the time of implementation, a proactive and user-centred
approach to ensuring data quality was important. The DELPHI team worked closely with the
participants to provide additional training and support, as well as to emphasize the importance of
consistent data entry. Furthermore, an ongoing quality monitoring system was developed to
improve data completeness and standardization across the sites 69.
The DELPHI Project for the current analysis consisted of twenty-four primary care
physicians and four nurse practitioners from ten practices. About five years of patient data have
been extracted since October 1, 2005, and the database contained records of approximately
30,000 patients and more than 550,000 encounters. These records, extracted quarterly, include
information such as billing codes, problem lists, medication lists, laboratory tests, procedures,
investigations, immunizations, clinical notes, and referrals. All these data were extracted without
any identifying information, such as provider name, patient name, health card number, full date
of birth or full postal code; and each participating patient and provider was given a unique study
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identifier 69. Furthermore, the pooled database was accessible only to DELPHI Project staff, who
were required to sign strict confidentiality agreements.

3.3.2. The International Classification of Primary Care (ICPC)
One of the research-oriented data input technologies incorporated into the DELPHI
database and the Healthscreen Solutions Inc. software was the International Classification of
Primary Care, Revised Second Edition (ICPC-2-R) coding system 73, 74. The ICPC-2-R system,
which is simply termed ICPC herein, was used by the DELPHI Project to allow for more
detailed classification of patient encounters than is usually available in an EMR. The ICPCcoded data captured important aspects of a primary care encounter, including reasons for
encounter for each visit (recorded from the patient’s own words), the diagnoses for each visit
(decided and recorded by the provider), and the tracking of diagnoses during a clinical episode of
care 69. This system is structured into seventeen “chapters”, which represent systems of the
human body. For example, chapter “D” corresponds to the digestive system and its related
health conditions, whereas chapter “R” corresponds to the respiratory system and its related
health conditions. To encourage ease of use, the coding of health conditions is as consistent as
possible throughout each of the ICPC chapters. That is, a code of _28 designates “Limited
function/disability” in each of the seventeen chapters.
In order to facilitate the participating providers’ transition into this coding system, a
gradual uptake was conducted, with two patients being randomly selected for ICPC coding each
day from the provider’s list. The DELPHI team recognized that a “ramp-up” method of
implementation would be the most ideal approach, as this method would not overwhelm the
already busy providers who were just beginning to gain familiarity with a new coding system.
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The participating health care providers were continuously trained on proper ICPC coding and a
final random sample of approximately 10% of the total DELPHI patient population was
achieved. To create a longitudinal record for each ICPC-selected patient, each subsequent inoffice visit by that patient was coded using ICPC. As of June 30, 2010, there were 3,341 ICPC
patients contributing more than 50,000 ICPC-coded visits in the DELPHI database.
The ICPC classification system is structured with two main foci of coding: Reason for
Encounter and End of Visit codes, which work separately to represent the patient perspective and
the provider perspective. The details of this ICPC structure can be seen in Figure 2. The RFE
codes were recorded based on the patient’s perspective of why they came into the office for a
visit with their primary care provider. These reasons may have involved symptoms or
complaints, such as whether the patient was experiencing a headache or fatigue; they may have
involved interventions or processes, such as whether a patient’s visit was for a diagnostic test or
medication renewal; or the reason for the visit may have involved specific diagnoses, such as
when a patient knew that the visit was specifically to address a previously diagnosed condition
of, for example, pneumonia or multiple sclerosis. The other component of ICPC coding was the
End of Visit codes, which were recorded by the provider themselves after the patient’s visit.
Again, this coding could have involved a symptom code (for example, the headache may have
simply remained as a headache at the end of the visit) or a diagnosis code for a condition that
was diagnosed at this or a previous visit.
Within this study, both the case and comparison patients were identified using the RFE
symptom codes. The case patients were identified with the symptom RFE of A04, while the
potential comparison patients were derived from one of the remaining 320 RFE symptom codes.
The complete list of the 321 symptom RFE codes can be found in Appendix A. The symptom
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and diagnosis End of Visit codes (recorded by the provider) were utilized to account for the
number of previous and co-occurring morbidities experienced by each case and comparison
patient. This distinction is displayed in Figure 2, and its purpose is discussed in further detail in
Section 3.8.6.
The ICPC system has notable advantages for its use in primary health care delivery. This
system groups problems into chapters that are relevant to clinical medicine (similar to the
ICD-10) 75. Its terms included undifferentiated problems (such as fatigue and “not otherwise
specified/NOS” codes), which have been found to comprise 50% of a primary care provider’s
workload 76-78. It also includes the RFE codes, which are based on information provided by the
patients themselves. Additionally, ICPC has been translated into twenty languages, making it
ideal for comparisons across countries and across populations 75, 79, 80.
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Figure 2: Structure of the ICPC-2-R* Coding System

Symptoms and Complaints
1

Reason for Encounter1
Recorded from the
Patient’s Perspective

Examples: headache, fatigue
ICPC Codes: _01 to _29

Interventions and Processes
Examples: diagnostic tests,
medication
ICPC Codes: _30 to _69

2

End of Visit Codes2

Recorded from the
Provider’s Perspective

Diagnoses

Examples: pneumonia,
multiple sclerosis
ICPC Codes: _01 to _29
1

Reason for Encounter codes utilized for case and comparison symptom group identification
End of Visit codes utilized for previous and co-occurring morbidity (chronic, psychosocial,
other) identification
2

*Adapted From: World Organization of National Colleges, Academies, and Academic
Associations of General Practitioners/Family Physicians. ICPC-2-R: International Classification
of Primary Care. 2nd ed. Oxford, New York: Oxford University Press, 2005.
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3.4. Data Structure
Two main structural elements were imposed on the available EMR data: the definition
and creation of an index visit for each included patient, and the creation of a case and
comparison patient group for the subsequent analysis.

3.4.1. Definition and Creation of an Index Visit
In order to establish that the included patients were all experiencing incident symptoms,
an index visit was defined for each patient. An eligible index visit for both the case and
comparison patients required three components: 1) a complete one year run-in period of ICPC
coding preceding the visit date; 2) a complete one year follow-up period of ICPC coding
following the visit date; and 3) that at least one of the symptom RFEs presented at the visit date
was not presented at any other in-office visits in the one year period preceding the visit date. If
all three conditions were met, the patient was considered to have an eligible index visit. For the
case patients, the symptom RFE that was presented at the index visit must have been an RFE of
fatigue; while the comparison patients could have presented with an RFE of any of the remaining
symptoms (non-fatigue RFEs). An eligible index visit was not excluded if the patient presented
with the same symptom RFE during the following year. To reiterate, a case patient was allowed
to have a subsequent visit for the symptom of fatigue during the following year.
Imposing the structure of a run-in period created an incidence group of symptom patients,
while the follow-up period structure was required to capture the dependent variables. Only one
index visit was identified per patient, and each patient was included only once. Examples of
eligible and ineligible index visits for both case and comparison patients can be found in Figure
3. Patient A was excluded as he/she did not have sufficient ICPC coding for one year prior to the
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visit date and therefore did not have a complete run-in period. Patient B was excluded due to the
fact that he/she did not have a sufficient follow-up period. Patient C was excluded due to
insufficient run-in and follow-up periods. Although Patient D did have a complete one year runin period and a complete one year follow-up period, such patients were ultimately excluded due
to a previous in-office visit with the same symptom less than one year prior to the potential index
visit date. In comparison, Patient E (representing a case patient) and Patient F (representing a
comparison patient) were both included as they satisfied all three inclusion criteria, and remained
eligible (as per our definition), even when a subsequent visit in the following year had the same
symptom RFE presented.
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Figure 3: Eligible and Ineligible Index Visits for Case and Comparison Patients
Patient A: Excluded Due to Incomplete Run-In Period
ICPC Coding
Begins

Beginning of
One Year RunIn Period

ICPC Coding
Ends

Visit Date with
RFE Symptom
(A04 or Non-A04)

End of One
Year FollowUp Period

Patient B: Excluded Due to Incomplete Follow-Up Period
ICPC Coding
Begins

ICPC Coding
Ends

Beginning of
One Year RunIn Period

End of One
Year FollowUp Period

Visit Date with
RFE Symptom
(A04 or Non-A04)

Patient C: Excluded Due to Incomplete Run-In and Incomplete Follow-Up Periods
ICPC Coding
Ends

ICPC Coding
Begins

Beginning of
One Year RunIn Period

Visit Date with
RFE Symptom
(A04 or Non-A04)

End of One
Year FollowUp Period
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Patient D: Excluded Due to Ineligible Index Visit
ICPC Coding
Begins

Beginning of
One Year RunIn Period

Previous Visit With
Same Symptom
RFE

ICPC Coding
Ends

End of One
Year FollowUp Period

Visit Date with
Symptom RFE
(A04 or Non-A04)

Patient E: Eligible Index Visit for Case Patients
ICPC Coding
Begins

Beginning of
One Year RunIn Period

Subsequent Visit
With RFE of
A04

Previous Visit With
Symptom RFEs
(Non-A04)

Index Visit Date with
RFE of A04

ICPC Coding
Ends

End of One
Year FollowUp Period

Patient F: Eligible Index Visit for Comparison Patients
Subsequent Visit
With Same
Symptom RFE

ICPC Coding
Begins

Beginning of
One Year RunIn Period

Index Visit Date with
Symptom RFE

ICPC Coding
Ends

End of One
Year FollowUp Period
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3.4.2. Case-Comparison Study Design
Previous research examining fatigue within populations has employed both
quantitative 4, 23, 24, 28, 39, 67, 68 and qualitative 21, 29, 81, 82 methods. As the current study was utilizing
a retrospective dataset, a selected number of research designs were possible. A recent study (in
which a case-comparison study was not used) stated that the use of a control group from the
general patient population would have been beneficial in making clear the degree to which the
volume of health care use among the fatigue patient population was indeed much higher than that
of the “normal” or “average” patients 83. Additionally, after applying the inclusion and exclusion
criteria to the ICPC patients who had presented with the symptom of fatigue, the resulting
sample size and power in determining significant differences within the analyses were
reduced 84. Consequently, a comparative study was deemed suitable and beneficial in that it not
only allowed for an increase in sample size and resulting study power 84, but it also allowed for
the fatigue symptom patients and their resulting health care utilization patterns to be placed in
context with a comparable group of primary care attenders.

3.5. Study Populations
Both the case and the comparison patient groups were drawn from the ICPC
subpopulation of the DELPHI database. A complete flowchart of patient inclusion for the case
and comparison patient groups can be found in Figure 4.
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Figure 4: Flow Chart of Patient Inclusion for Case and Comparison Patient Groups
DELPHI Patient Population
N = 29,303
ICPC Patient Population
n = 3,341
Case Patients

Patients with > 1 Visit with an
RFE of A04
n = 274
Patients Excluded Due To Not
Meeting Two Full Years (Run-In and
Follow-Up) of ICPC Coding Criteria
n = 146
Patients with Complete One Year Run-In
Period and Complete One Year Follow-Up
Period of ICPC Coding
n = 128
Patients Excluded Due To Not
Meeting Incident Fatigue Criteria
n = 22
Patients with an Eligible Index
Visit for Fatigue
n = 106
Patients Excluded Due To Not
Meeting > 19 Years of Age Criteria
n=3
Adult Patients with an Eligible Index
Visit for Fatigue and Complete One
Year Run-In and One Year Follow-Up
Period of ICPC Coding
n = 103

Comparison Patients

Patients with > 1 Visit with a
Symptom RFE (not A04)
n = 3,064
Patients Excluded Due To Not
Meeting Two Full Years (Run-In and
Follow-Up) of ICPC Coding Criteria
n = 1,525
Patients with Complete One Year Run-In
Period and Complete One Year Follow-Up
Period of ICPC Coding
n = 1,557
Patients Excluded Due To Not
Meeting Incident Symptom Criteria
n = 315
Patients with an Eligible Index
Visit for Symptom
n = 1,242
Patients Excluded Due To Not
Meeting Matching Criteria
n = 387
Eligible, Matched Comparison Patients
n = 855

Random Selection of Matched,
Comparison Patients
n = 103
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3.5.1. Unit of Analysis
An important consideration in studying health care utilization was defining an
appropriate unit of analysis. The choices of the unit of analysis were: the visit; the episode of
care; or the patient 58. This selection was influenced by whether health services were assessed
visit-by-visit during a given period of time or whether the purpose of the study was to assess the
number of services received throughout the illness duration or the entire “episode of care” 58, 85.
An episode of care approach attempts to delineate a particular illness experience and all of the
associated medical care, which is beneficial when studying questions involving care associated
with specific diagnoses, the continuity of care received, or the level of patient compliance 58, 85.
In comparison, the current study examined the health care utilization patterns during a given
period of time after an incident contact with a primary care provider, in which the characteristics
of the patient were of primary importance in determining the overall volume of services 58. As
having the visit as the unit of analysis results in counting a patient multiple times (for each of
their visits during the data collection period), the objectives of the current study were tailored to
having individual and independent patients followed over time, and having each patient included
only once. There is a growing need to understand health service delivery on a longitudinal basis,
which can be done by using the patient as the unit of analysis 86. Therefore, the unit of analysis
for the current study was defined as the patient.

3.5.2. Fatigue Symptom Patients
The case patients were identified as having presented to their primary care provider with
an RFE of A04 at least one time during the data collection period: from March 1, 2006 to June
30, 2010. The ICPC description for the A04 code was “Weakness/tiredness general”, which
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included a spectrum of fatigue conditions: chronic fatigue syndrome, exhaustion, fatigue,
lassitude, lethargy, and postviral fatigue 87. This definition of fatigue was validated and vetted by
health professionals during the development of the ICPC 73, 74. The A04 code was simply
referred to as “fatigue” herein. Within the current study, the period prevalence of the symptom of
fatigue among ICPC-coded patients was found to be 8.2%, in that 8.2% of ICPC-coded patients
had at least one in-office visit with an RFE of fatigue during the data collection period. The final
number of eligible fatigue symptom or case patients was 103 patients.

3.5.3. Comparison Patient Group
The use of a comparison group can be a powerful quantitative research tool, with valid
conclusions hinging on establishing an appropriate comparative sample 88. In recognition of this
fact, careful consideration was used in determining the most suitable comparison group for the
current study. Potential comparison groups and the sequence of decisions during this process are
described in Appendix B. It was ultimately decided to compare the fatigue symptom patients, or
the case patients, to average or typical symptom patients from the larger ICPC patient
population. This final comparison group was structured as an incidence symptom group (the
same structure as the fatigue symptom patients) and consisted of ICPC patients who had an index
visit for any RFE-coded symptom, with the exception of the symptom of fatigue (RFE of A04).
Only symptom RFE codes (ICPC codes _01 to _29) were of interest for identifying the
comparison patients, and so the RFE codes from the rubrics: “Investigations and Processes”
(ICPC codes _30 to _69), and “Diagnoses” (ICPC codes _70 to _99) were not eligible. These
excluded RFE codes can be found in Appendix C. Described previously, the comparison
patient’s index visit was structured in the same way as for the fatigue symptom patients, in that a
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visit was only considered suitable if it had met the criteria of: a complete run-in period of ICPC
coding; a complete follow-up period of ICPC coding; and that the symptom RFE presented at
that visit date was not presented at a previous visit within the previous year. Suitable comparison
patients were then evaluated based on the matching criteria (described in Section 3.5.4), and
randomly selected without replacement.

3.5.4. Matching Criteria for the Case and Comparison Patients
The purpose of a control group was to represent those patients who were at risk of
becoming a case patient. Matching criteria were applied to ensure that this comparative study
examining health care utilization patterns was not biased or influenced by differences in baseline
characteristics between the two patient groups (or that these differences were reduced). As has
been shown in previous literature and in a number of health care utilization theories, multiple
factors influenced health resource use 57, 59, 89, 90 . As described in an earlier section (see Section
3.2.), these factors can be needs-based, predisposing or contextual factors, at the practice-,
provider-, and patient-level. Comparison patients with an acceptable index visit were matched to
the case patients on five variables: patient sex, patient age (age window of ±5 years), practice
number, provider number, and the quarter of the index date. As baseline differences between the
case and comparison patients may have caused an effect on the observed differences in the
dependent variables, it was important to ensure that the comparative groups did not differ
significantly for these variables. However, it was also noted that once the patients were matched
on these five predictive variables, their effects could no longer be analyzed. The final number of
eligible comparison patients was 855 patients, from which one matched patient was randomly
selected for each case patient (resulting in a 1:1 matching ratio).
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The patient-level predisposing factors of sex and age have been shown to have a positive
correlation with increasing health care utilization 58, 89, 91-93. As well, the time of year in which a
patient attended their family physician may have influenced the degree of health care utilization.
For example, seasonal illnesses, such as respiratory infections or influenzas, tended to be
correlated with significant increases in health care utilization rates, producing an increased
demand of health care personnel, acute care, and testing and treatment protocols 94, 95. The
influence of practice-level factors can be the result of a number of factors, including: variation in
geographic location (rural versus urban location); the social or economic status of the patient
group being serviced by the practice; and the resources available to the practice (for example,
proximity to a high density specialist population) 1, 89, 91-93. Finally, primary care physicians have
traditionally been seen as the “gatekeeper” of health care, in that, particularly in the Canadian
context, receiving a referral from the family physician was required for a patient to be seen or
treated by a specialist 71, 72. It has been demonstrated that physician characteristics, including sex,
age, areas of specialty and years of medical practice significantly influenced the rate of referral
or investigations administered for their patients 71, 89, 91.

3.6. Data Validity
Quality of data was an important consideration when conducting secondary analyses of
an existing database for research. Valid and accurate conclusions are essential in health care
research, as findings can have implications for patient care, physician performance, and policy
development 96. As EMRs are principally designed to support clinical care delivery, they are
not structured in a way that easily facilitates use in research 97, 98. Routine EMR use by health
care providers influences the usability and validity of the EMR-derived data. Characteristics of
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provider use that negatively influence resulting data include: the lack of standardization of use
among all providers or health care practices, which produces variability among providers and
uniqueness of data entry; the preference for narrative entries over coding data with defined fields
or structured medical lists; the lack of a standardized interpretation of clinical terms among
providers; data recording in areas or fields that are not readily accessible for researchers (for
example, free text entries); and that data not directly related to clinical care are often
significantly under recorded 97. Each of these characteristics can produce variability and
missingness in the data, which ultimately reduce the quality of the data. Within the EMR
literature, the three main components of data quality include the concepts of completeness,
correctness and comparability. These terms used within the EMR literature can be closely
aligned to specific epidemiologic concepts. The relation between the EMR literature concepts
and the associated epidemiologic concepts can be found in Figure 5.
Completeness assesses whether an electronic medical record includes all relevant
information for all possible patients. This concept can be associated with the epidemiological
concept of sensitivity, in that it measures the proportion of observations that are actually
recorded in the system 96. As the number of false negatives (patients that truly have a condition
or symptom, but were not captured by the measure) increases, the sensitivity or completeness of
the data subsequently decreases 84, 96. The completeness of the EMR data can also be influenced
by the degree of missingness within the dataset. As mentioned previously, many characteristics
of EMR use by health care providers can produce significant levels of missing or misclassified
data. If a reasonable proportion of data are missing or misclassified due to differences in use
among providers, various approaches to replacing this missing data with valid estimates are
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possible (as will be discussed in Section 3.9.3.). Although it is an important area for future
research, assessing the completeness of the data was beyond the scope of the current study.
Correctness evaluates whether electronic data have been recorded appropriately and
accurately, particularly as compared to a gold standard 99. Accuracy of data recording is
dependent on whether the disease or condition identified is truly present in the patient, which is
similar to the epidemiological concept of positive predictive value 84, 96. As stated by Neal et al.
(1996), electronic records can be considered valid “when all those events that constitute a
medical record are correctly recorded and all the entries in the record truly signify an event” 100.
Similar to the structure of specificity, as the number of false positives (patients that are recorded
as having a condition or symptom, but truly do not) increases, the positive predictive value or the
correctness of the data decreases 84, 96. While the positive predictive value represents the
proportion of observations that represents the true state of a patient, the accuracy of the EMR
data describes the proportion of all recorded EMR data that are correct 84. Correctness is also
related to the concept of content validity, which describes whether the EMR data measures and
includes all of the dimensions of the construct it was intended to measure 84. Within the current
study, the content of the ICPC coding system was validated and vetted by health professionals
during the development of the ICPC 73, 74. Furthermore, an inclusion and exclusion criteria were
provided by the World Organization of National Colleges, Academies and Academic
Associations of General Practitioners/Family Physicians (WONCA) committee in order to
promote correct and consistent coding of health conditions 73, 87. Finally, the use of a gold
standard (such as an administrative database, disease registry or clinical values) as tool to
determining the degree of correctness in an EMR database has been demonstrated in a number of
previous studies 96, 98, 101, 102. Work has also been done to develop validated EMR definitions for
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specific diseases or conditions, such as diabetes 103, 104. However, determining the correctness of
the data recorded was out of the scope of the current study.
Comparability of the EMR data constitutes whether the data produce similar
demographic and disease prevalence profiles with that of an external population 98, 102. This is
similar to the epidemiological concept of generalizability, which expresses the validity of
assuming that patients in a specific sample population truly represents patients in the broader
population 84, 105. Similar to generalizability, external validity is the degree to which the results
from a dataset are applicable in other settings or to other patients 84. Furthermore, the
comparability of EMR-derived data can be aligned with the epidemiological concept of
reliability. The reliability of an effective measurement means that it will yield the same observed
results when applied repeatedly 105. The comparability of the EMR-derived data was specifically
assessed in the current study by evaluating the results from the analyses in the context of
previous literature with comparable samples and settings. Additionally, the demographics of the
DELPHI patient population, from which the sample was derived for this study, was compared to
the Canadian Census Population in order to assess the appropriateness of generalizing the
findings from this study to the larger Canadian population (as will be described in Section
5.5.2.).
Previous literature has recognized that EMR-derived data represented a significant source
of information that was not readily captured through other data collection methods 97. As a result,
research using this data source will provide important insight into primary health care delivery
and health care utilization, when used appropriately and with great care 79. Although it was out of
the scope of the current study, continuing work on assessing the validity and quality of EMRderived data for use in future research is essential.
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Figure 5: Relation between EMR Literature Concepts and Epidemiologic Concepts
EMR Literature Concept

Epidemiologic Concept

1.Completeness

a) Sensitivity
b) Missingness

2. Correctness

a) Positive Predictive Value
b) Content Validity
c) Gold Standard

3. Comparability

a) Generalizability/External Validity
b) Reliability
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3.7. Definition and Creation of Dependent Variables
Three dependent variables were defined: the number of subsequent visits; the number and
type of referrals; and the number of laboratory tests and investigations. These dependent
variables were initially described in a descriptive manner to satisfy Objective One, and then were
modeled as count variables for the multivariable models and to satisfy Objective Two and
Objective Three. A summary of the dependent variables can be found in Table 1.

3.7.1. Number of Subsequent Visits
The number of subsequent visits variable was derived from the “Schedule” data file of
the EMR software. This separate dataset included every in-office visit each patient had with their
primary care provider, as well as the associated visit date. This dependent variable was defined
as the number of in-office visits by a patient during the one year follow-up period for both the
case and comparison patients. Consequently, all visits occurring after the index date (not
including the index visit date itself) and during the one year follow-up period were included in
the variable. Any visits occurring before the index date or after the follow-up period were not
included. If a patient did not experience a visit throughout the follow-up period, the number of
subsequent visits was equal to zero. For descriptive and analytic purposes, this variable was
structured as an interval and count variable, respectively. Furthermore, this outcome variable was
only able to capture health care visits to one source of health care services (primary care
providers), and therefore could not account for other health care resources that may have been
utilized by the patient following the index visit (such as hospital visits, allied health professionals
at another location, complementary and alternative health care, and walk-in clinics).
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3.7.2. Number and Type of Referral
The number and type of referrals variable was derived from the “Consultations” data file
of the EMR software. This separate dataset included the referrals that occurred for each patient,
the date the referral was initiated by the primary care provider, and the specialist service the
patient was referred to. The referral variable was defined as the number and type of referrals
made at the index visit date or during the one year follow-up period for both the case and
comparison patients. Consequently, all referrals that were initiated on the index date or during
the following year were included in the variable. Any referrals occurring after the follow-up
period or anytime before the index date were excluded. Additionally, if a recorded referral was
determined to be for a “Consult Report” or a “Read Report” (as noted in the referral description),
it was subsequently excluded, to ensure a reasonable level of construct validity for this
dependent variable and to avoid an overestimation of referrals for the two groups of patients. If a
patient did not have a referral recorded throughout the follow-up period, the number of referrals
was equal to zero. For descriptive and analytic purposes, this variable was structured as an
interval and count variable, respectively.
The type of referrals was also evaluated for descriptive purposes. The type of
consultation specialty was re-coded to identify medical specialties recognized by the Ontario
Health Insurance Plan (OHIP) and the Royal College of Physicians and Surgeons of Canada 106.
The “Paediatrics” category from the OHIP specialty list was excluded as no patients under the
age of nineteen years were included in the current study. Three additional referral type
categories, not currently identified by OHIP, were also incorporated. A “General Practice”
category was added to capture referrals that were made among general practitioners; a
“Hospital/Specialty Clinic” category was added to capture referrals to settings with physicians

47
from multiple specialties or referrals to a specialty clinic (for example, pain clinics or sleep
clinics); and an “Other Services/Unknown” category was added to capture referrals that were
coded as “Other Services”, referrals that were non-medical specialty referrals (for example, a
referral for optometry), and referrals that did not have any associated medical specialty type
coded in the dataset, therefore the referral type was unknown. Accordingly, there were 35
possible referral type categories and the complete list can be found in Appendix D.

3.7.3. Number of Laboratory Tests and Investigations
The number of laboratory tests and investigations variable was derived from the “Labs
Ordered” and “Investigations” data files of the EMR software. These separate datasets included
the tests and investigations that were ordered for each patient and the date the test or
investigation was initiated by the primary care provider. These two datasets were mutually
exclusive in that they represented two distinct uses of investigative health resources: examination
of a sample (laboratory tests, derived from the “Labs Ordered” data) and examination of a person
(imaging tests, derived from the “Investigations” data). Although this variable was a composite
of two measures, this variable was simply termed as the number of investigations herein. The
investigations variable was defined as the total number of clinical investigations (that is the sum
of the number of laboratory tests and the number of investigations) that were ordered by the
primary care provider at the index visit date or during the one year follow-up period for both the
case and comparison patients. Consequently, all investigations that were initiated on the index
date or during the following year were counted in the variable. Any investigations with an
associated date occurring after the follow-up period or anytime before the index date were not
included. If there were no associated investigations during the follow-up period, the number of
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investigations was equal to zero. Examples of data entries that were included in this dependent
variable can be found in Appendix E.
To ensure that each data entry represented a singular test among the “Labs Ordered” data,
a multiplicative factor was applied to data entries that were assumed to represent multiple tests.
For example, based on information from the Laboratory Test Information Guide, a resource
utilized by the London Laboratory Services Group for London Health Sciences Centre and St.
Joseph’s Health Care London, a “CBC” was identified as generally producing three broad types
of laboratory tests: cell count, hematocrit testing and hemoglobin testing 107. As a result, a factor
of three was applied to each “CBC” data entry. A similar process was done for “Lipid
Assessment” (multiplicative factor of three applied) and “Urinalysis” (multiplicative factor of
two applied). However, this data coding issue was found not to be an issue for the investigations
data. For descriptive and analytic purposes, the number of laboratory tests and investigations was
structured as an interval and count variable, respectively. Furthermore, this outcome variable was
only able to capture the laboratory tests and investigations that were ordered or initiated by the
primary care provider; whether the patient actually received the test or investigation was not
evaluated.
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Table 1: Summary of Dependent Variables

Dependent Variable

Definition

Descriptive
Analysis Structure
(Objective One)

Multivariable
Analysis Structure
(Objective Two
and Objective Three)

Number of Subsequent
Visits

Number of in-office
provider visits during
the one year follow-up
period

Interval Variable

Count Variable

Number of Referrals

Number of referrals
during the one year
follow-up period

1. Interval Variable
2. Type Categorization

Count Variable

Number of Laboratory
Tests and Investigations

Number of laboratory
tests and investigations
during the one year
follow-up period

Interval Variable

Count Variable
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3.8. Definition and Creation of Independent Variables
The main independent variable for this study was the classification of patients into the
case or comparison patient groups. The other independent variables, to be described in
subsequent sections, were classified into two strata: provider- or practice-level variables and
patient-level variables. A summary of the dependent variables can be found in Table 2.

3.8.1. Main Independent Variable: Case vs. Comparison Patient
Identifying a patient as belonging to the case or comparison patient group created the
main independent variable (described in detail in the previous Section 3.5.). Again, evaluating
the differences in health care utilization between the case and comparison patients was one of the
principal objectives of the current study. This status differentiated patients as having an incident
symptom of fatigue (case group) or as having another, non-fatigue incident symptom
(comparison group). Based on previous literature, it was hypothesized that fatigue symptom
sufferers would experience different utilization patterns than patients suffering from the other,
comparison symptoms. While this nominal variable was noted as the main independent variable;
the remaining independent variables are described in the following sections.

3.8.2. Provider-Level and Practice-Level Variables
The provider- and practice-level variables were controlled for using the unique study
identifier of both the primary care provider and the primary care practice. As was described
previously in Section 3.5.4., the effects of these variables on resulting health care use were not of
interest for the current study; instead, their potential effects were adjusted for through matching
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and adjustment in the multivariable analyses. The remaining independent variables were all
within the patient-level stratum.

3.8.3. Patient-Level Variable: Age
The age of each patient was calculated at the point each patient entered the study, which
was one year prior to their individual index visit date. Patients who were under nineteen years of
age were not included in this study. The decision to exclude child and adolescent patients who
presented with the symptom of fatigue was based on previous literature that has concluded that
both the presentation and the experience of symptoms of fatigue can be significantly different
among children and adolescents as compared to adult patients 108-111. Similarly, comparison
patients who were under the age of nineteen years were not included. In the final sample of case
patients, only three patients were under nineteen years of age and were subsequently excluded
(leaving a final sample size of 103 patients). For Objectives One and Two, age was modeled as a
continuous variable. For Objective Three, the age of each patient was used as a matching
criterion; therefore the influence of age on the resulting health care utilization patterns was no
longer assessed.

3.8.4. Patient-Level Variable: Sex
The sex of each patient was modeled as a binary variable (male and female) for
Objectives One and Objective Two. For Objective Three, the sex of each patient was used as a
matching criterion; therefore the effect of patient sex on health care utilization patterns was no
longer assessed.
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3.8.5. Patient-Level Variable: Morbidity
The level of previous and co-occurring morbidity was captured by creating three separate
independent variables: previous and co-occurring chronic morbidities, previous and co-occurring
psychosocial morbidities, and previous and co-occurring other morbidities. Each of these
variables was a distinct and separate measure of morbidity, and were not categorized in a
mutually exclusive or hierarchical manner. Each will therefore be described on its own. In
reference to these variables, the terms “morbidity” and “condition” will be used interchangeably
herein. The previous and co-occurring morbidities were counted using the symptom or diagnosis
End of Visit codes that were recorded for each patient during the one year run-in period and/or at
the index visit. In order to ensure a clear distinction between how these variables were counted
and how the case and comparison patients were identified; separate parts of the ICPC system (the
End of Visit codes and the RFE codes, respectively) were used (see Figure 2). This was done to
avoid a tautology of the definition of these three independent variables and the definition of our
case and comparison patients.

3.8.5a. Previous and Co-Occurring Chronic Morbidities
The criteria for identifying previous and co-occurring chronic conditions were derived
from the published list by O’Halloran et al. in 2004 112. This list identified 126 ICPC-coded
conditions that were both relevant to primary care and that met characteristics significant to
defining a chronic morbidity. These conditions were had a duration that lasted, or was expected
to last, at least 6 months; had a pattern of recurrence; had a poor prognosis or deterioration; and
had physical or mental consequences or sequelae that impacted the patient’s quality of life 112.
These criteria were then applied to each term within the ICPC and a final code set of 126 chronic
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conditions was established, and can be found in Appendix F. More specifically, the 126 chronic
morbidities were identified through the End of Visit symptom and diagnosis codes of the ICPC.
Although this list was developed to identify chronic conditions managed in an Australian general
practice setting, this list was considered suitable for identifying chronic conditions in a Canadian
primary care setting. Consequently, this list was used to identify the number of previous and cooccurring chronic morbidities of both the case and comparison patients. All chronic morbidities
that were presented at the index visit or at in-office visits in the previous year were included. For
descriptive purposes, the number of previous and co-occurring chronic morbidities was defined
as a continuous variable.

3.8.5b. Previous and Co-Occurring Psychosocial Morbidities
The number of previous and co-occurring psychosocial conditions was identified using
two ICPC-defined chapters, as well as individual “Fear and Concern” codes from each chapter.
The two included chapters represented psychological conditions (any code from chapter “P”) and
social problems (any code from chapter “Z”), while the remaining codes captured fear or concern
issues relating to a specific body system (for example, a fear of cancer of the digestive system or
a fear of skin disease). These psychosocial conditions were identified through the End of Visit
symptom and diagnosis codes of the ICPC, similar to the identification of the previous and cooccurring chronic morbidities. The validation of ensuring that these codes captured psychosocial
conditions was previously completed by the international WONCA committee 73, 74. The final list
included 42 psychological conditions, 26 social problems, and 43 fear and concern conditions.
The final list of the 111 previous and co-occurring psychosocial morbidities can be found in
Appendix G. All psychosocial morbidities that were presented at the index visit or at in-office
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visits in the previous year were included. For descriptive purposes, the number of previous and
co-occurring psychosocial morbidities was defined as a continuous variable.

3.8.5c. Previous and Co-Occurring Other Morbidities
The morbidities experienced by a patient that were not chronic or psychosocial in nature
were captured by the number of previous and co-occurring other morbidities variable. These
previous and co-occurring other morbidities included the non-chronic, non-psychosocial
conditions experienced by the patient during the one year run-in period or at the index visit. Like
the previous and co-occurring chronic and psychosocial conditions, these codes were identified
through the End of Visit symptom and diagnosis codes of the ICPC. The codes A96 (“Death”),
A97 (“No disease”), and A98 (“Health maintenance/preventive medicine”) were excluded as
these codes did not represent diagnosable conditions. The complete list of previous and cooccurring other morbidities can be found in Appendix H. All other morbidities that were
presented at the index visit or during the previous year were included. Although this variable’s
impact on subsequent health care utilization patterns was not a main focus of the current study, it
was important to capture the presence of other co-occurring conditions among the case and
comparison patients. For descriptive purposes, the number of previous and co-occurring other
morbidities was defined as a continuous variable.

3.8.6. Patient-Level Variable: Previous Care-Seeking Frequency
The previous care-seeking frequency variable was derived from the “Schedule” data file
of the EMR software. Previous care-seeking frequency was defined as the number of in-office
visits during the one year run-in period for both the case and comparison patients. Consequently,
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all visits occurring before the index date (not including the index visit date itself) and during the
one year run-in period were included in the variable. Any visits occurring after the index date or
before the run-in period were not included. If a patient did not have an in-office visit in the year
preceding the index visit, the patient’s previous care-seeking frequency was equal to zero. This
variable was used to capture the frequency of primary health care use before the event of the
index visit and to assess whether an increase in a patient’s “exposure” (that is, increased health
service use prior to the index visit) was associated with an increase in health care use following
the index visit. This variable was only able to capture health care visits to one source of health
care services (primary care providers), and therefore could not account for other health care
resources that may have been utilized by the patient prior to the index visit (such as hospital
visits, allied health professionals, complementary and alternative health care, and walk-in
clinics). For descriptive purposes, previous care-seeking frequency was defined as a continuous
variable.
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Table 2: Summary of Independent Variables
Independent Variable

Definition

Variable Type
Objective One

Objective Two and
Objective Three
Dichotomous
Case Patient
Comparison Patient

Case

Classification of case and
comparison patients

Age

Patient age in years

Continuous

Sex

Sex of the patient

Dichotomous
Male
Female

Previous and CoOccurring Chronic
Morbidities

Number of chronic
conditions presented
during the one year runin period and/or at the
index visit date

Continuous

Continuous

Previous and CoOccurring Psychosocial
Morbidities

Number of psychosocial
conditions presented
during the one year runin period and/or at the
index visit date

Continuous

Continuous

Previous and CoOccurring Other
Morbidities

Number of other
conditions presented
during the one year runin period and/or at the
index visit date

Continuous

Continuous

Previous Care-Seeking
Frequency

Number of in-office
visits during the one year
run-in period

Continuous

Continuous
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3.9. Statistical Analysis
The data analyses for this study were carried out in two phases. The first phase involved
describing the fatigue symptom patient population (descriptive analysis) and developing a model
of covariates that might influence the health care utilization patterns of the fatigue symptom
patients (multivariable analysis). This was done to address Objective One and Objective Two.
The second phase involved comparing the utilization patterns of the fatigue symptom patients to
those of the matched, comparison group (multivariable analysis). This was done to address
Objective Three. All data analyses were conducted using the statistical software, Stata 10.0.

3.9.1. Descriptive Analysis
The descriptive analyses were conducted on our fatigue symptom patient sample
consisting of 103 patients. In order to satisfy Objective One of this study and to characterize a
patient who presents to their primary care provider with a symptom of fatigue, the distributions
of the independent and dependent variables were explored. As well, the most frequent types of
previous and co-occurring chronic, psychosocial, and other morbidities were determined. The
most frequent types of specialist referrals were also described.

3.9.2. Multivariable Analysis
A series of analytic models were created in order to satisfy Objective Two and Objective
Three of this study. These statistical analyses were conducted separately for each of the three
dependent variables: the number of subsequent visits, the number of referrals, and the number of
laboratory tests and investigations. The level of significance for these analyses was set at 0.05.
The initial descriptive and bivariate analyses provided insight into the appropriate model
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construction for each of the dependent variable models, which is detailed later in Section 3.9.7.
and Section 3.9.8.

3.9.3. Missing Data
As was described earlier in Section 3.6., the completeness of data entry was an important
factor in ensuring quality of EMR-derived data, and therefore valid results. In the following
section, several aspects of missing data are described. Firstly, where possible, the level of
completeness of the independent and dependent variables was assessed based on the work of
previous EMR research. Secondly, missingness of data was an issue for one of the dependent
variables and was subsequently addressed. Thirdly, although the remaining independent and
dependent variable data were more complete; even a small amount of missing data could have
potentially resulted in an underestimation of the prevalence of morbidity or the related health
care resource utilization.
Regarding the first point, previous research has demonstrated high rates of completeness
for consultation or visit recording. In seven studies examining this variable, the extent of
electronic consultation recording was consistently above 90% 98, 100, 113-117. For morbidity coding,
previous research has demonstrated variability in the degree of completeness, ranging from 67%
to 99% 113, 115-117. However, a higher degree of recording does not necessarily mean that all
problems brought forward or addressed during the primary care encounter were fully recorded 99.
General care providers suggested that mental and psychological problems were under-recorded
due in part to difficulty in coding these issues 116. In comparison, conditions with clear diagnostic
features, such as diabetes or high blood pressure, had higher quality of recording than conditions
with more subjective criteria, such as asthma or depression 99.
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Incomplete coding may have resulted in an underestimation of the number of previous
and co-occurring morbidities experienced by patients within our sample; however, this was not
seen as a significant issue in the identification of the case and comparison patients. This
identification process was through the patient-provided Reason for Encounter codes, which were
coded from the patient’s perspective. External health system factors may also have distorted
coding practices over time, such as through incentive-based coding specifically targeting a
certain diagnosis, intervention or investigation (for example, the Ontario provincial
government’s incentive to track clinical markers for diabetes patients) 79, 99. It was assumed that
the effects of these incentives were experienced consistently across the primary care practices.
As well, no known Ontario provincial government targets were in place that were particularly
relevant to the clinical conditions of interest for the current study.
While completeness and correctness of data entry rely heavily on the enthusiasm and
dedication of the practices and each participating health care provider, lack of consistent coding
can also be attributed to unavailability of a computer (such as during a transition of care or
during a home visit), or forgetfulness from the provider. Past research has demonstrated that
simple requests or feedback to those who are providing coded data can significantly improve the
consistency and completeness of the data 113, 114. As was stated in the previous section, the
accuracy and completeness of the EMR data for the DELPHI Project was initially targeted and
enhanced through site-specific training and a proactive, user-centred approach to encourage the
participating providers to code correctly and reliably 69. An ongoing quality monitoring system
has also been developed by the DELPHI team in order to maintain and improve that validity and
standardization of the data that are populating the DELPHI database.
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Regarding the second point, the completeness of one of the dependent variables, the
number of laboratory tests and investigations, was compromised within the database due to
missing data. This dependent variable was a composite of two distinct datasets within the EMR
and one of the datasets contained incomplete data. This missing data was a result of the
variability and uniqueness of how data were entered into the EMR by each practice. The “Labs
Ordered” dataset did not contain any information for Practice 1, as this practice had recorded
their laboratory test data in a different section of the EMR (a section that was not accessible to
the DELPHI research team). It was determined that the missingness of the laboratory test data for
the case and comparison patients from Practice 1 represented 7.9% of the total study sample
(n=16 patients). However, this data was “Not Missing at Random” (NMAR), as it was
systematically missing for patients coming from one specific practice 118-120. Although this
situation was not ideal, as the missingness of the data was correlated to another variable within
the study’s data matrix, the variability of the laboratory test data among the remaining practices
was evaluated and a process of addressing this missing data was undertaken.
Regarding the third point, there were a number of methods that could have been used for
handling missing data, including case deletion, likelihood-based estimation, simple imputation,
and multiple imputation 118, 119, 121. Each of these approaches had their benefits and limitations,
which were evaluated in the context of the laboratory test missing data. It was ultimately decided
to follow the simple imputation method of imputing unconditional means. As the mean number
of laboratory tests per practice was fairly consistent (producing an average of 25.6 laboratory
tests per practice during the one year follow-up period), it was concluded that the practices did
not vary considerably in the number of laboratory tests that were recorded, despite the fact that
they differed in how these data were recorded. This observation, combined with the fact that the
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missing data represented <10% of the total sample, lead to the reasonable decision to impute the
mean number of laboratory tests for the missing data. This procedure replaced the missing values
for the 16 patients with plausible estimates, as imputing unconditional means replaced each
missing item with the calculated mean from the observed values of laboratory tests during the
one year follow-up 120. In this way, the mean of the variable was preserved, but the variance and
covariance values were potentially biased. More specifically, as imputed data were not the true
data, the variance estimates were potentially reduced 120. In particular, as we are imputing data
for one of the dependent variables of the current study, the resulting findings must be interpreted
with caution. However, this potential bias was deemed suitable and as with any inference made
with missing data, the results were interpreted with caution. Additionally, the advantages of this
imputation approach were that it maintained valuable data and a complete dataset, on which
standard techniques and analyses were applied.

3.9.4. Collinearity
Potential collinearity among the independent variables was assessed through a correlation
matrix. This was done to ensure that the regression coefficients were as precise as possible and
that the final model was as parsimonious as possible. The inclusion of highly correlated variables
(with a correlation coefficient of higher than 0.36) in a multivariate model could significantly
alter the interpretation of the correlation coefficients 122. However, it was determined that none
of the covariates were highly correlated, and thus all covariates were subsequently considered for
the final models.
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3.9.5. Influential Points
The presence of influential points for the continuous independent variables was assessed
through the use of simple plots. The data were observed graphically to ensure that outlying
points were not leading the relationship between the independent and dependent variables 122.

3.9.6. Interactions
Examining potential interactions between the independent variables was not an a priori
objective of the current research study, as interactions among the variables in the current study
have not been shown in previous literature. Interaction terms were consequently not incorporated
into the final model as testing for all first-order interactions in a model consisting of multiple
predictors for an outcome would lead to false-positives 122.

3.9.7. Bivariate Analyses
Bivariate analyses were conducted between the three dependent variables and each of the
independent variables. Two sample t-tests and Pearson correlation coefficients were done to
detect significant relationships between the count dependent variables (number of subsequent
visits, number of referrals, and number of investigations) and the independent variables. These
exploratory analyses determined which independent variables were important for inclusion in the
final multivariate regression models. All variables with a p-value of 0.2 or less were included in
the final analysis, as suggested by Vittinghoff et al. (2005) 122. Additionally, three of the
independent variables (the number of previous and co-occurring chronic morbidities, the number
of previous and co-occurring psychosocial conditions, and previous care-seeking frequency)
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were forced into each of the three models in order to explicitly test the hypotheses of Objective
Two, which were described earlier in the Methodology chapter.

3.9.8. Negative Binomial Regression Model
A negative binomial regression (Stata command nbreg) was used to model the number of
subsequent visits, the number of referrals and the number of investigations of the case and
comparison patients during the one year follow-up period. Our dependent variable data were
over-dispersed and it was determined that each had an unconditional mean that was much lower
than the unconditional variance. Although a Poisson distribution can be utilized for count data,
this distribution holds the strong assumption that the mean and variance are equal; consequently,
this was not a suitable model for our data 123, 124. Instead, a negative binomial regression model
was used for over-dispersed count data; with unequal mean and variance values. A zerotruncated negative binomial regression model was not considered for any of the three dependent
variables as it was possible for the data to generate one or more zero counts. Likewise, no
negative counts were possible for any of the observed variables. A zero-inflated regression
model was considered as a possible model structure for the dependent variables with a
considerable number of zero counts in the entire sample. However, it was determined that there
were not an excess of zeros (less than 50%) for each of the three outcome variables;
consequently this extension was not necessary. A glm command was used to obtain the residuals
to check other assumptions of the negative binomial regression model. When required, an age
squared term was added to the model as age tends to have a non-linear relationship in regression
analyses 125. Lastly, a likelihood ratio test was also conducted to test and confirm that a negative
binomial regression model fit our data more suitably as compared to a Poisson distribution.
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3.9.9. Run-In and Follow-Up Period Sensitivity Analysis
A sensitivity analysis was conducted by altering the run-in and follow-up period length
for the fatigue symptom patient group. These periods were reduced from one year to six months
periods. The final multivariable models of each of the three dependent variables were replicated
using bivariate analyses in order to screen variables for inclusion into the final regression model
(p-value of 0.2 or less to meet the cut-off requirement for inclusion). This sensitivity analysis
was done by adjusting the criteria imposed on the original sample of fatigue symptom patients,
which subsequently increased the sample size of fatigue patients. The findings from these models
were compared to the relationships found from the original negative binomial regression models.
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CHAPTER FOUR – RESULTS
4.1. Objective One: Description of the Fatigue Symptom Patient Sample
The final sample of fatigue symptom patients consisted of 103 patients from March 1,
2006 to June 30, 2010. A description of the patient-level characteristics is provided in Table 3.
The demographic characteristics include the mean age (in years) and sex distribution of the
patients. As well, this table presents information regarding the distribution of the number of
previous and co-occurring chronic, psychosocial, and other morbidities among the sample; as
well as the five most frequent conditions presented by the fatigue patients during the one year
run-in period and/or at the index visit. The distribution of the number of subsequent visits, the
number of referrals, and the number of investigations experienced by these patients during the
one year follow-up period are described. The five most frequent types of specialist referrals
experienced by these patients during the follow-up period are also included.
The age distribution of the fatigue symptom patients was approximately normal with a
mean age of 63.1 years (SD=17.4) and range from 20 to 96 years. Sixty-eight percent of the
sample was female; thirty-two percent of the sample was male. The average number of previous
and co-occurring chronic morbidities among the fatigue symptom patients was 7.7 chronic
morbidities (SD=7.8) with a range from 0 to 42 conditions. The average number of previous and
co-occurring psychosocial morbidities among these patients was 2.9 psychosocial morbidities
(SD=4.7) with a range from 0 to 23 conditions. The average number of previous and cooccurring other morbidities was 10.5 morbidities (SD=10.4) with a range from 0 to 61
conditions. The average number of visits during the one year run-in period was 12.1 visits
(SD=11.6) and ranged from 0 to 69 visits. The majority (76.7%) of fatigue symptom patients had
at least five previous visits during the one year run-in period. A similar number of visits were
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experienced by these patients during the one year follow-up period, with a mean of 12.3 visits
(SD=11.4) and a similar range of 0 to 69 visits. Again, the majority (82.5%) of fatigue symptom
patients had at least one follow-up visit. The fatigue patients had an average of 2.3 referrals (SD=
3.1) with a range from 0 to 16; and an average of 20.2 investigations (SD=22.7) with a broad
range from 0 to 125 investigations. Approximately one third (35.9%) of the fatigue symptom
patients received no referrals during the one year follow-up period, whereas two thirds (67.0%)
of the sample experienced at least five investigations during the following year.
Previous and co-occurring chronic conditions were common among 88% of the fatigue
symptom patients. “Hypertension uncomplicated” was the most commonly experienced chronic
morbidity; while “Diabetes non-insulin dependent”, “Anxiety disorder/anxiety state”, “Ischaemic
heart disease with angina”, and “Depressive disorder” were the next most prevalent chronic
conditions. Previous and co-occurring psychosocial conditions were common among
approximately 52% of the fatigue symptom patients. “Anxiety disorder/anxiety state” was the
most prevalent psychosocial condition. As presented in Table 3, “Depressive disorder”,
“Relationship problem with partner”, “Sleep disturbance”, and “Partner illness problem” were
the next most frequent psychosocial conditions among the fatigue patients. Previous and cooccurring other conditions were common among 91% of the fatigue symptom patients. “Allergic
rhinitis” was the most frequently presented non-chronic, non-psychosocial (therefore other)
morbidity, which was followed by the next most common conditions of: “Skin disease other”,
“Shortness of breath/dyspnoea”, “Chest pain NOS”, and “Cough”. Finally, the most common
referral types for the fatigue symptom patients during the one year follow-up period were:
Dermatology, Internal Medicine, Neurology, Gastroenterology, and General Surgery.
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Table 3: Objective One – Description of the Fatigue Symptom Patient Sample (N=103)
Characteristic
Age
Sex
Previous and Co-Occurring
Chronic Morbidity

Distribution

Description1

Previous and Co-Occurring
Psychosocial Morbidity

Distribution

Description1

Description/Frequency (%)
Mean

63.1 years (SD:17.4)

Range

20 - 96 years

Male

33 (32.0%)

Female

70 (68.0%)

Mean
Range

7.7 conditions (SD:7.8)
0 - 42 conditions

0 Conditions

12 (11.7%)

1 Condition

7 (6.8%)

2 Conditions

8 (7.8%)

3 Conditions

14 (13.6%)

4 Conditions

9 (8.7%)

5 or more Conditions

53 (51.5%)

Hypertension uncomplicated

157 (19.7%)

Diabetes non-insulin dependent

100 (12.6%)

Anxiety disorder/anxiety state
Ischaemic heart disease with
angina
Depressive disorder

85 (10.7%)

Mean
Range

47 (5.9%)
33 (4.1%)
2.9 conditions (SD:4.7)
0 - 23 conditions

0 Conditions

49 (47.6%)

1 Condition

8 (7.8%)

2 Conditions

12 (11.7%)

3 Conditions

6 (5.8%)

4 Conditions

2 (1.9%)

5 or more Conditions

26 (25.2%)

Anxiety disorder/anxiety state

85 (28.1%)

Depressive disorder
Relationship problem with
partner
Sleep disturbance

33 (10.9%)
25 (8.3%)
22 (7.3%)

Partner illness problem
19 (6.3%)
Percentage of ‘Description’ may not add up to 100% as more than one condition could have
been presented by each patient
1
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Table 3: Description of the Fatigue Symptom Patient Sample Continued (N=103)
Characteristic
Previous and Co-Occurring
Other Morbidity

Distribution

1

Description

Previous Care-Seeking
Frequency

Distribution

Description/Frequency (%)
Mean

10.5 conditions (SD:10.4)

Range

0 - 61 conditions

0 Conditions

9 (8.7%)

1 Condition

3 (2.9%)

2 Conditions

4 (3.9%)

3 Conditions

9 (8.7%)

4 Conditions

11 (10.7%)

5 or more Conditions

67 (65.0%)

Allergic rhinitis

83 (7.7%)

Skin disease other

39 (3.6%)

Shortness of breath/dyspnoea

36 (3.3%)

Chest pain NOS

30 (2.8%)

Cough

30 (2.8%)

Mean

12.1 visits (SD:11.6)

Range

0 - 69 visits

0 Visits

2 (1.9%)

1 Visit

4 (3.9%)

2 Visits

3 (2.9%)

3 Visits

12 (11.7%)

4 Visits

3 (2.9%)

5 or more Visits
Number of Subsequent Visits

Distribution

79 (76.7%)

Mean

12.3 visits (SD:11.4)

Range

0 - 69 visits

0 Visits

1 (1.0%)

1 Visit

6 (5.8%)

2 Visits

4 (3.9%)

3 Visits

1 (1.0%)

4 Visits

6 (5.8%)

5 or more Visits
85 (82.5%)
Percentage of ‘Description’ may not add up to 100% as more than one condition could have
been presented by each patient
1
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Table 3: Description of the Fatigue Symptom Patient Sample Continued (N=103)
Characteristic
Number of Referrals

Distribution

Description2

Number of Laboratory Tests and
Investigations

Distribution

Description/Frequency (%)
Mean

2.3 referrals (SD:3.1)

Range

0 - 16 referrals

0 Referrals

37 (35.9%)

1 Referral

16 (15.5%)

2 Referrals

17 (16.5%)

3 Referrals

11 (10.7%)

4 Referrals

6 (5.8%)

5 or more Referrals

16 (15.5%)

Dermatology

36 (15.1%)

Internal Medicine

25 (10.5%)

Neurology

22 (9.2%)

Gastroenterology

18 (7.5%)

General Surgery

17 (7.1%)

Mean

20.2 investigations (SD:22.7)

Range

0 - 125 investigations

0 Investigations

8 (7.8%)

1 Investigation

10 (9.7%)

2 Investigations

4 (3.9%)

3 Investigations

6 (5.8%)

4 Investigations

6 (5.8%)

5 or more Investigations
2

69 (67.0%)

Percentage of referral ‘Description’ may not add up to 100% as more than one referral could
have been experienced by each patient
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4.2. Objective Two: Determinants of Number of Subsequent Visits
4.2.1. Bivariate Analyses
The bivariate analyses between the number of subsequent visits during the one year
follow-up period and each of the independent variables for the fatigue symptom patients
(N=103) is presented in Table 4. Statistically significant relationships were found between the
number of subsequent visits and the number of previous and co-occurring other morbidities
(r=0.43, p<0.001); as well as between the number of subsequent visits and previous care-seeking
frequency (r=0.71, p<0.001). Statistically significant relationships were not found between the
number of subsequent visits and patient sex (p=0.185), patient age (p=0.726), the number of
previous and co-occurring chronic morbidities (p=0.104), and the number of previous and cooccurring psychosocial morbidities (p=0.635). Correlation between the number of subsequent
visits and the remaining dependent variables was also assessed, and although the relationship
between the number of subsequent visits and the number of referrals was insignificant, the
relationship between the number of subsequent visits and the number of investigations was found
to be significant (p<0.001).

4.2.2. Multivariable Analysis
A negative binomial regression was used to model the number of subsequent visits. The
clustering of patients within physician and practices was adjusted for with robust standard errors.
Variables included in the final regression model were selected from the results of the bivariate
analyses, as each variable with a test significance of 0.2 or less was included. This resulted in the
exclusion of patient age (p=0.726). The number of previous and co-occurring psychosocial
morbidities (p=0.635) was forced into the model, despite its large p-value, in order to test the
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hypotheses presented in Objective Two. Table 5 presents the results of the final multivariable
analysis, reporting the incidence rate ratio (IRR) for each independent variable in which all other
variables in the model were held constant.
Based on the results of the final model seen in Table 5, the number of subsequent visits
did not differ significantly between male and female fatigue symptom patients (p=0.398). As
well, the presence of previous and co-occurring morbidities of any type (chronic, psychosocial,
and other) did not have a statistically significant influence on the number of subsequent visits
experienced by the patients during the one year follow-up period (all p-values were >0.05).
However, for each visit increase in the fatigue patient’s previous care-seeking frequency, the
number of subsequent visits increased by 4% (IRR=1.04, p<0.001). For each increase in the
number of investigations, the number of subsequent visits increased by 1% (IRR=1.01, p<0.001).
Additionally, the significant result of the likelihood ratio test confirmed that the data were overdispersed and were therefore more appropriately described by a negative binomial regression
distribution as compared to a Poisson distribution.
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Table 4: Bivariate Analyses of Number of Subsequent Visits (N=103)
n

Mean

SD

p-value1

Male

33

10.18

9.11

0.185

Female

70

13.37

12.20

Characteristic
Sex

1
2

r

p-value2

Age

0.03

0.726

Previous and Co-Occurring Chronic Morbidities
Previous and Co-Occurring Psychosocial
Morbidities
Previous and Co-Occurring Other Morbidities

0.16

0.104

0.05

0.635

0.43

<0.001

Previous Care-Seeking Frequency

0.71

<0.001

Number of Laboratory Tests and Investigations

0.36

<0.001

Results from two-sample t-tests
Results from correlation coefficients
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Table 5: Multivariable Negative Binomial Regression Analyses of Number of Subsequent
Visits (N=103)
95%
Confidence
Interval

p-value

0.87 - 1.44

0.398

-

-

-

Previous and Co-Occurring
Chronic Morbidities2

1.01

1.00 - 1.03

0.182

Previous and Co-Occurring
Psychosocial Morbidities3

1.01

0.98 - 1.03

0.656

Previous and Co-Occurring
Other Morbidities4

1.00

0.98 - 1.01

0.739

Previous Care-Seeking Frequency5

1.04

1.03 - 1.06

<0.001

Number of Laboratory Tests and
Investigations6

1.01

1.00 - 1.01

<0.001

Incidence Rate
Ratio

Characteristic
Sex

Age1

Male

1.00

Female

1.12

Likelihood Ratio Test7
Chi-Squared = 202.16
p-value <0.001
1
IRR of a one-point increase in the age (in years)
2
IRR of a one-point increase in the number of previous and co-occurring chronic morbidities
3
IRR of a one-point increase in the number of previous and co-occurring psychosocial
morbidities
4
IRR of a one-point increase in the number of previous and co-occurring other morbidities
5
IRR of a one-point increase in the previous care-seeking frequency (in visits)
6
IRR of a one-point increase in the number of laboratory tests and investigations
7
Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data
are more adequately modeled using a negative binomial regression distribution as compared to a
Poisson distribution
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4.3. Objective Two: Determinants of Number of Referrals
4.3.1. Bivariate Analyses
The bivariate analyses between the number of referrals during the one year follow-up
period and each of the independent variables for the fatigue symptom patients (N=103) is
presented in Table 6. A statistically significant relationship between the number of referrals and
patient sex was found, as male patients had a higher average number of referrals during the one
year follow-up period compared to the female patients (average of 3.94 referrals compared to an
average of 1.56 referrals, p<0.001). As well, a statistically significant relationship was found
between the number of referrals and the number of previous and co-occurring chronic
morbidities among the patients (r=0.30, p=0.003) and the previous care-seeking frequencies of
the patients (r=-0.12, p=0.023). Statistically significant relationships were not found between the
number of referrals and patient age (p=0.494), the number of previous and co-occurring
psychosocial morbidities (p=0.166), and the number of previous and co-occurring other
morbidities (p=0.062). Correlation between the number of referrals and the remaining dependent
variables was also assessed, but the relationships were found to be highly insignificant.

4.3.2. Multivariable Analysis
A negative binomial regression was used to model the number of referrals. The clustering
of patients within physician and practices was adjusted for with robust standard errors. Variables
included in the final regression model were selected from the results of the bivariate analyses,
with each variable having a test significance of 0.2 or less being included. Therefore, patient age
(p=0.494) was excluded. Table 7 presents the results of the final multivariable analysis, reporting
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the incidence rate ratio for each independent variable in which all other variables in the model
were held constant.
Based on the results of the final model seen in Table 7, the number of referrals differed
significantly between male and female fatigue symptom patients, with females receiving 59%
less referrals during the follow-up period as compared to male patients (IRR=0.41, p<0.001).
The presence of previous and co-occurring chronic and psychosocial morbidities did not have a
statistically significant influence on the number of subsequent referrals during the following
year, with p-values equal to 0.327 and 0.484, respectively. However, it was found that the
number of referrals increased by 5% with each additional non-chronic, non-psychosocial (other)
condition experienced by these patients (IRR=1.05, p<0.001). A statistically significant
relationship was also found between the previous care-seeking frequencies of the fatigue
symptom patients and subsequent referral. For each increase in the number of previous visits, the
patients were 4% less likely to receive a referral following the index visit (IRR=0.96, p=0.002).
Additionally, the significant result of the likelihood ratio test confirmed that the data were overdispersed and were therefore more appropriately described by a negative binomial regression
distribution as compared to a Poisson distribution.
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Table 6: Bivariate Analyses of Number of Referrals (N=103)
n

Mean

SD

p-value1

Male

33

3.94

4.24

<0.001

Female

70

1.56

2.10

Characteristic
Sex

1
2

r

p-value2

Age

0.07

0.494

Previous and Co-Occurring Chronic Morbidities
Previous and Co-Occurring Psychosocial
Morbidities
Previous and Co-Occurring Other Morbidities

0.30

0.003

0.14

0.166

0.18

0.062

Previous Care-Seeking Frequency

-0.12

0.023

Results from two-sample t-tests
Results from correlation coefficients
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Table 7: Multivariable Negative Binomial Regression Analyses of Number of Referrals
(N=103)
95%
Confidence
Interval

p-value

0.25 - 0.67

<0.001

-

-

-

Previous and Co-Occurring
Chronic Morbidities2

1.01

0.99 - 1.03

0.327

Previous and Co-Occurring
Psychosocial Morbidities3

1.02

0.97 - 1.06

0.484

Previous and Co-Occurring
Other Morbidities4

1.05

1.02 - 1.07

<0.001

Previous Care-Seeking Frequency5

0.96

0.93 - 0.98

0.002

Incidence Rate
Ratio

Characteristic
Sex

Age1

Male

1.00

Female

0.41

Likelihood Ratio Test6
Chi-Squared = 59.77
p-value <0.001
1
IRR of a one-point increase in the age (in years)
2
IRR of a one-point increase in the number of previous and co-occurring chronic morbidities
3
IRR of a one-point increase in the number of previous and co-occurring psychosocial
morbidities
4
IRR of a one-point increase in the number of previous and co-occurring other morbidities
5
IRR of a one-point increase in the previous care-seeking frequency (in visits)
6
Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data
are more adequately modeled using a negative binomial regression distribution as compared to a
Poisson distribution
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4.4. Objective Two: Determinants of Number of Laboratory Tests and Investigations
4.4.1. Bivariate Analyses
The bivariate analyses between the number of laboratory tests and investigations during
the one year follow-up period and each of the independent variables for the fatigue symptom
patients (N=103) is presented in Table 8. To account for the statistically significant correlation
between the number of investigations and the number of subsequent visits during the one year
follow-up period, the number of subsequent visits was also included as a covariate in the
multivariable regression model. A statistically significant relationship was found between the
number of laboratory tests and investigations and the number of previous visits (r=0.11,
p=0.081), as well as the number of subsequent visits (r=0.36, p<0.001). However, statistically
significant relationships were not found between the number of investigations and the remaining
variables: patient sex (p=0.604), patient age (p=0.525), the number of previous and co-occurring
chronic morbidities (p=0.553), the number of previous and co-occurring psychosocial
morbidities (p=0.391), and the number of previous and co-occurring other morbidities (p=0.313).

4.4.2. Multivariable Analysis
A negative binomial regression was used to model the number of laboratory tests and
investigations. The clustering of patients within physician and practices was adjusted for with
robust standard errors. Variables included in the final regression model were selected from the
results of the bivariate analyses, as each variable having a test significance of 0.2 or less was
included. Therefore, patient age (p=0.525), patient sex (p=0.604), and the number of previous
and co-occurring other morbidities (p=0.313) were excluded. However, the number of previous
and co-occurring chronic morbidities (p=0.553) and the number of previous and co-occurring
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psychosocial morbidities (p=0.391) were forced into the model in order to test the hypotheses
presented in Objective Two. Table 9 presents the results of the final multivariable analysis,
reporting the incidence rate ratio for each variable in which all other variables in the model were
held constant.
Based on the results of the final model seen in Table 9, the number of laboratory tests and
investigations remained statistically significantly related to the number of previous and
subsequent visits made by the fatigue symptom patients. For each visit increase in the fatigue
patient’s previous care-seeking frequency, the number of subsequent investigations decreased by
4% (IRR=0.96, p=0.006). In contrast, each visit increase in the number of following visits
produced a 5% increase in the number of subsequent investigations during the one year followup period (IRR=1.05, p<0.001). However, the number of chronic or psychosocial conditions
among the patients did not significantly influence the resulting number of laboratory tests and
investigations administered during the follow-up period, with p-values of 0.964 and 0.197,
respectively in the final model. Lastly, the significant result of the likelihood ratio test confirmed
that the data were over-dispersed and were therefore more appropriately described by a negative
binomial regression distribution as compared to a Poisson distribution.
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Table 8: Bivariate Analyses of Number of Laboratory Tests and Investigations (N=103)
n

Mean

SD

p-value1

Male

33

17.33

23.01

0.604

Female

70

19.83

22.60

Characteristic
Sex

1
2

r

p-value2

Age

0.06

0.525

Previous and Co-Occurring Chronic Morbidities

0.06

0.553

Previous and Co-Occurring Psychosocial
Morbidities
Previous and Co-Occurring Other Morbidities

0.09

0.391

-0.10

0.313

Previous Care-Seeking Frequency

0.11

0.081

Number of Subsequent Visits

0.36

<0.001

Results from two-sample t-tests
Results from correlation coefficients
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Table 9: Multivariable Negative Binomial Regression Analyses of Number of Laboratory
Tests and Investigations (N=103)
Incidence Rate
Ratio

Characteristic
Sex

95%
Confidence
Interval

p-value

Male

-

-

-

Female

-

-

-

-

-

-

Previous and Co-Occurring
Chronic Morbidities2

1.01

0.97 - 1.04

0.964

Previous and Co-Occurring
Psychosocial Morbidities3

1.04

0.98 - 1.09

0.197

Previous and Co-Occurring
Other Morbidities4

-

-

-

Previous Care-Seeking Frequency5

0.96

0.95 - 0.99

0.006

Number of Subsequent Visits6

1.05

1.03 - 1.07

<0.001

Age1

Likelihood Ratio Test7
Chi-Squared = 1490.56
p-value <0.001
1
IRR of a one-point increase in the age (in years)
2
IRR of a one-point increase in the number of previous and co-occurring chronic morbidities
3
IRR of a one-point increase in the number of previous and co-occurring psychosocial
morbidities
4
IRR of a one-point increase in the number of previous and co-occurring other morbidities
5
IRR of a one-point increase in the previous care-seeking frequency (in visits)
6
IRR of a one-point increase in the number of subsequent visits
7
Likelihood Ratio Test denotes a significant over-dispersion of the data, indicating that the data
are more adequately modeled using a negative binomial regression distribution as compared to a
Poisson distribution
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4.5. Overview of Findings from Multivariable Analyses
In order to provide a cohesive review of the findings from the three multivariable models,
Table 10 details the significant relationships (both in the positive and negative directions) that
were found between the model covariates and each of the dependent variables.

4.6. Objective Three: Differences in Health Care Utilization between Comparative Groups
4.6.1. Baseline Characteristics of Case and Comparison Patients
The distributions of the baseline characteristics for both the case and comparison patient
groups, as well as the distributions of these characteristics for the overall sample, are presented
in Table 11. After the matching process was conducted, the fatigue symptom patients and the
comparison patients were of similar age (mean of 63.1 years, median of 64.0 years) and sex
composition (32.0% male and 68.0% female). The case and comparison patients were also
similar in their baseline numbers of previous and co-occurring chronic and psychosocial
morbidities. However, results from the two sample t-tests showed that the patient groups were
significantly different in the number of previous and co-occurring non-chronic, non-psychosocial
(other) morbidities (p=0.033) and in their previous care-seeking frequencies (p=0.032). The case
patients had a higher baseline level of previous and co-occurring other morbidities (average of
10.5 other morbidities for fatigue symptom patients as compared to the average of 7.7 other
morbidities for the comparison patients). As well, the fatigue symptom patients had a
significantly higher level of previous care-seeking than the comparison group (average of 12.1
visits for the case patients as compared to the average of 9.2 visits for the comparison patients).
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Table 10: Overview of Multivariable Regression Analyses Findings
Dependent Variable
Characteristic

Number of
Subsequent Visits

Number of
Referrals

Number of
Laboratory Tests
and Investigations

Age

−

Female
Number of Previous and CoOccurring Chronic Morbidities
Number of Previous and CoOccurring Psychosocial Morbidities
Number of Previous and CoOccurring Other Morbidities
Previous Care-Seeking Frequency

+
+

−
+

Number of Subsequent Visits
Number of Laboratory Tests and
Investigations

−

+

NOTE:
+ Indicates a statistically significant positive relationship
− Indicates a statistically significant negative relationship
An empty box indicates no statistically significant relationship in the multivariable analysis or
p>0.2 in the bivariate analysis
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Table 11: Baseline Characteristics of Comparative Patient Groups and Overall Sample
Fatigue Symptom
Group (N=103)
Mean
Median
(SD)

Comparison
Group (N=103)
Mean
Median
(SD)

All Patients
(N=206)
Mean
Median
(SD)

63.1
(17.4)

64.0

64.0
(17.2)

65.0

63.5
(17.3)

64.0

0.715

70
33

(68.0%)
(32.0%)

70
33

(68.0%)
(32.0%)

140
66

(68.0%)
(32.0%)

1.00

Number of Previous and
Co-Occurring Chronic
Morbidities

7.7
(7.8)

5.0

6.0
(8.8)

3.0

6.9
(8.4)

4.0

0.142

Number of Previous and
Co-Occurring
Psychosocial
Morbidities

2.9
(4.7)

1.0

2.4
(5.1)

1.0

2.7
(4.9)

1.0

0.417

Number of Previous and
Co-Occurring Other
Morbidities

10.5
(10.4)

7.0

7.7
(8.1)

5.0

9.1
(9.4)

6.0

0.033

Previous Care-Seeking
Frequency

12.1
(11.6)

9.0

9.2
(6.7)

8.0

10.7
(9.6)

8.0

0.032

Number of Subsequent
Visits

12.3
(11.4)

9.0

8.6
(6.9)

7.0

10.5
(9.6)

8.0

Number of Referrals

2.3
(3.1)

1.0

2.1
(2.9)

1.0

2.2
(3.0)

1.0

Number of Laboratory
Tests and Investigations

20.2
(22.7)

12.0

11.1
(13.7)

5.0

15.6
(19.2)

8.0

Characteristic
Age
Sex, n (%)
Female
Male

1

p-value1

Results comparing case group and comparison group baseline characteristics using two sample
t-tests
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4.6.2. Multivariable Analysis
The results of the three negative binomial regression models for assessing the health care
utilization differences between the case and comparison patient groups are displayed in Table 12.
In each of these models, the variable “Case” was included as a predicting variable. Again, each
incidence rate ratio was reported, in which all other variables in the model were held constant.
An important consideration for each of these models was the inclusion of and adjustment for the
matching criteria variables (patient age, patient sex, practice number, provider number, and the
quarter of the index visit date). Furthermore, it is important to note that since the comparison
patients were selected at random from the larger eligible comparison patient group (consisting of
855 patients), different results may be obtained if the random selection process and the analyses
were conducted again. Based on the results of these models seen in Table 12, the fatigue symptom
patients had a significantly greater number of in-office primary care visits and a significantly
greater number of laboratory tests and investigations during the one year follow-up period, as
compared to the non-fatigue symptom patients. More specifically, the case patients experienced
19% more subsequent visits (IRR=1.19, p=0.038) and 68% more laboratory tests and
investigations (IRR=1.68, p<0.001) in comparison to the other symptom patients. However, the
case and comparison patient groups were found not to be significantly different in the number of
specialist referrals received during the one year follow-up period (IRR=0.97, p=0.845). Therefore,
overall, the case and comparison patients were significantly different in their number of
subsequent visits and their number of laboratory tests and investigations during the one year
follow-up period, yet they did not differ significantly in their number of referrals received during
the following year.
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Table 12: Multivariable Negative Binomial Regression Analyses for Case and Comparison
Patients (N=206)

1

Incidence Rate
Ratio

95%
Confidence
Interval

p-value

Negative binomial
regression model

1.191

1.01 - 1.41

0.038

Number of Referrals

Negative binomial
regression model

0.972

0.71 - 1.32

0.845

Number of Laboratory Tests
and Investigations

Negative binomial
regression model

1.683

1.26 - 2.24

<0.001

Dependent Variable

Regression Model

Number of Subsequent Visits

IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider
number and quarter of index visit) and the remaining independent variables (number of previous
and co-occurring chronic morbidities, number of previous and co-occurring psychosocial
morbidities, number of previous and co-occurring other morbidities and previous care-seeking
frequency); and the number of laboratory tests and investigations
2
IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider
number and quarter of index visit) and the remaining independent variables (number of previous
and co-occurring chronic morbidities, number of previous and co-occurring psychosocial
morbidities, number of previous and co-occurring other morbidities and previous care-seeking
frequency)
3
IRR calculated by adjusting for matched variables (age, age2, sex, practice number, provider
number and quarter of index visit); the remaining independent variables (number of previous and
co-occurring chronic morbidities, number of previous and co-occurring psychosocial
morbidities, number of previous and co-occurring other morbidities and previous care-seeking
frequency); and the number of subsequent visits
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4.7. Results of the Run-In and Follow-Up Period Sensitivity Analysis
The results of the sensitivity analysis for the Number of Subsequent Visits, the Number
of Referrals, and Number of Laboratory Tests and Investigations dependent variables can be
found in Appendix I, Appendix J, and Appendix K, respectively. In each table, the first column
outlines the significant relationships between the model covariates and the dependent variable
during a six month run-in and follow-up period. The second column represents the findings from
our original multivariable analyses; in which a full twelve month run-in and follow-up period
was used (this column was shaded to differentiate the findings). After reducing the required runin and follow-up periods to six months, the sample of patients who had presented with an index
visit for the symptom of fatigue, and who had complete six month run-in and follow-up periods,
became 167 patients. Despite this increase in sample size, the results were largely the same as the
initial analysis done with our original fatigue symptom patient group consisting of 103 patients.
All significant relationships (and the associated direction of the relationship) within each of the
multivariable analyses were maintained. One additional finding from the sensitivity analyses was
in the multivariable model for the number of laboratory tests and investigations. Originally, there
was no significant relationship between the sex of the patient and the number of subsequent
investigations. However, after conducting the sensitivity analysis, the sex of the patient was
found to be significantly and positively related with the number of investigations administered in
the following year. In contrast to the findings for the number of subsequent referrals (which
found that female patients were significantly less likely to receive a referral in the following
year), the female patients were found to experience 67% more investigations during the
following year, as compared to the male patients (IRR=1.67, p=0.016). This is a marked
difference as compared to our original findings, and demonstrates the need for examining the
influence of gender on fatigue patient’s use of health services in future studies.
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CHAPTER FIVE – DISCUSSION
The purpose of the last chapter of this thesis will be to compare our results to the existing
literature; to present interpretations for our key findings; to highlight the strengths and
limitations of the current study; to outline the implications of our findings and the directions of
future research; and finally, to discuss the conclusions of this work. To provide a broad overview
of the key results presented in the previous chapter, the fatigue symptom patients were found to
have significant rates of referrals (within the group itself) and investigations (in comparison to
other symptom patients) in the year following the index date; the sex of the fatigue symptom
patients significantly influenced the frequency of referral; and the previous care-seeking
frequency of the patients was significantly related to each of the dependent variables, but in
varying directions.

5.1. Objective One: Description of Fatigue Symptom Patients
We found a period prevalence of 8.2% of fatigue symptom presentation among the entire
ICPC patient population, during our data collection period between March 1, 2006 and June 30,
2010. Although there has been a wide range of prevalence estimates of fatigue in primary care
settings in previous literature, this period prevalence was comparable to two studies conducted in
somewhat similar settings and among similar populations of patients. In the Netherlands,
“fatigue” is recorded as the Reason for Encounter for 6.3% of the patients in general practice 126.
This comparable finding was derived from a fairly similar setting of general practice clinics
(although the study was conducted in the Netherlands) and had data derived from the same
classification system of the ICPC. A Canadian study conducted by Cathebras et al. (1992) in
Montreal, Quebec found that of 686 patients who presented to two family medicine clinics,
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13.6% of these patients presented with a complaint of fatigue 39. Within this study, the presence
of fatigue was self-reported by the patients and the primary care visits were self-initiated, which
was similar to the current study. The Cathebras et al. study identified fatigue as a presenting
complaint in two ways: 1) the patient mentioned “fatigue” or a closely related response (such as
being “tired” or “drained”) when asked by the health care staff, “Why did you see the doctor
today?” or 2) the patient stated to the physician directly that their presenting complaint was
fatigue 39. Although the identification of patients was not as structured as the ICPC system, and
despite the fact that this prevalence value was obtained twenty years ago, this study provided a
valuable reference point of the estimated prevalence of fatigue symptoms in a Canadian primary
care population.
The majority (68%) of our fatigue patient sample were female, which was in agreement
with many other studies that have shown the presentation of fatigue symptoms skewed towards
women. Our proportion of females was slightly higher than the proportions found by Bensing et
al. (1990) (37.8% female), but slightly less skewed towards females than the Ridsdale et al.
(1994) study (75.5% female) 28, 68. However, our proportion of female patients was particularly
similar to the Canadian study by Cathebras et al., in which 65.6% of patients presenting with a
new symptom of fatigue to their primary care provider were women 39. The average age of our
fatigue symptom patient sample was 63.1 years, which was an older patient sample compared to
other studies. For example, the studies by Ridsdale et al. and Cathebras et al. each had a much
younger population of patients who presented to their primary care clinic with the complaint of
fatigue; with mean ages of 43 years and 43.2 years, respectively 28, 68.
The average number of visits prior to the index visit was found to be 12.1 visits, and
76.7% of the fatigue symptom patients had at least five previous visits during the one year run-in
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period. This finding was markedly higher than the Ridsdale et al. study based in four primary
care practices in England, which found an average of 6.2 visits by fatigue patients during the
year before the fatigue-related visit 68. In comparison, an average of 17.1 medical visits per year
by chronic fatigue patients was found in an American university-based chronic fatigue clinic 24.
This count of medical visits included a wide range of health care professionals and captured
health care use among a more severely fatigued patient population. However, the fact that our
average number of previous medical visits is somewhat comparable to this study based in a
tertiary care clinic is potentially important in that it signifies a level of health care use by our
primary care patients that is comparable to fatigue patients requiring specialized care.
While 64.1% of fatigue symptom patients received at least one referral from their
provider following the index visit, 92.2% of the sample had at least one laboratory test or
investigation in the following year. In a study of fatigue patients in a Dutch primary care
population, only about 4.0% of the patients received a referral to another health care professional
during the observation period (which was approximately four years); whereas the most frequent
laboratory test and investigations administered to these patients were: blood tests (75.7% of
patients), physical examinations (49.5% of patients), health education (34.2% of patients), urine
testing (4.9% of patients), and imaging (2.4% of patients) 23. This study, conducted by Kenter et
al. (2003) examined the clinical episode of care for fatigue, which differed from the current
study’s structure. Kenter et al. found that over a four year period, 21% of patients (from a basic
primary care population of 12,292 patients) started a new episode of care with the symptom of
fatigue 23. This episode of care structure allowed for the measurement of health care utilization
that resulted directly from or was clinically related to the fatigue presentation 23. In comparison,
the current study examined associations between the fatigue presentation and resulting health
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care utilization over a one year period, but did not specifically assess causal relationships. These
differences, and differences in patterns of care in the Netherlands as compared to Canada, were
likely the reason of the variation in the frequency of referrals and investigation in our group of
fatigue symptom patients (high frequencies of referral and investigation) and the group of fatigue
patients in the Kenter et al. study (low frequencies of referral and investigation).
Considerably high numbers of previous and co-occurring morbidities were found among
our fatigue symptom sample. Firstly, the average number of previous and co-occurring chronic
conditions was as high as 7.7 conditions. In previous literature, patients with a chronic disease
often reported symptoms of fatigue 15, and likewise, the prevalence of chronic disease was higher
among patients presenting with fatigue than among other patients 3. An average of 2.9
psychosocial conditions was also found among our fatigue patients. Since previous studies have
demonstrated a strong association between the presentation of fatigue and significant
psychological distress 4, 39, 68, this average of psychosocial morbidity was less than what was
expected. Finally, the number of non-chronic, non-psychosocial conditions among these patients
was found to be an average of 10.5 conditions. This large burden of “other” conditions was not
found to be represented in previous fatigue literature, and therefore could be an important
addition to the existing literature.
When adding the average numbers of chronic (7.7), psychosocial (2.9), and other (10.5)
morbidities together, the overall average of previous and co-occurring morbidity for our fatigue
patients was approximately 21.1 conditions over a one year run-in period. In the study conducted
by Kenter et al. (2003), fatigue symptom patients were found to have an average co-morbidity
count of 16.6 conditions, which was slightly, but not markedly less than the level of morbidity in
our fatigue patient sample 23. The evaluation of fatigue symptom patients demonstrates a
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significant burden of complex morbidity, which may be an influential factor in their subsequent
management and health care utilization.
To summarize, comparable findings from the existing literature were present for the sex
distributions (more specifically, the skewed representation of female patients in fatigue patients),
as well as for the complex of co-occurring morbidity for our fatigue symptom patients. However,
it was noted that the number of previous and co-occurring psychosocial conditions among our
patients was less than what was expected, based on the existing literature which has consistently
demonstrated high correlations between psychosocial morbidity and fatigue presentation.
Conflicting results in the previous care-seeking frequency among fatigue patients was evident in
the literature. Finally, non-comparable findings from the existing literature were present for the
approximate age of an average fatigue patient (in that our fatigue patient population was
markedly older than fatigue populations in previous studies) and the frequency of referrals and
investigations experienced by these patients (as our patients experienced a decidedly higher
number of referrals and investigations when compared to previous studies).

5.2. Objective Two: Description of Health Care Utilization of Fatigue Symptom Patients
The second objective assessed the health care utilization patterns of fatigue symptom
patients, and analyzed the relationship between the covariates (patient age, patient sex, number
of previous and co-occurring morbidity, and previous care-seeking frequency) and each of the
three outcome variables (number of subsequent visits, number of referrals, and number of
laboratory tests and investigations). To examine these relationships more specifically, two
hypotheses were tested.
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Hypothesis 1: It was hypothesized that a fatigue symptom patient who presented with an
increased number of chronic or psychosocial previous and co-occurring conditions would
experience an increased level of health case use (that is an increased number of subsequent visits,
referrals, and investigations during the one year follow-up period), adjusting for all other
variables. This was hypothesized based on the conceptual framework stating a potential
relationship between the disease burden experienced by these patients (therefore translated to an
increased perceived or evaluated need) and subsequent health care use. However, this hypothesis
was not reflected in the results of the three multivariable models for the fatigue symptom
patients. In all three cases, when the number of chronic and psychosocial conditions were tested
in the bivariate analyses and forced into the multivariable models, significant relationships
between these independent variables and the dependent variables were not found.
There have been few prior studies examining the relationship between symptom
presentation, associated levels of morbidity, and resulting health care utilization. In fact, no
previous studies have tested these relationships using each of the three dependent variables of the
current study. A study conducted by Stoller (1988) reported that while the number of physical
morbidities or symptoms was correlated with the number of prescribed medications, the level of
morbidity was not associated with the number of physician visits 127. Our findings regarding the
number of chronic and psychosocial morbidities would concur with Stoller’s observed
association with the number of physician visits, but our findings regarding the remaining
outcomes (referrals and investigations) are new to the literature. Further interpretation of these
results will be presented later.
Hypothesis 2: It was hypothesized that a fatigue symptom patient who had an increased
previous care-seeking frequency would experience an increased level of health care use (that is
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an increased number of subsequent visits, referrals, and investigations during the one year
follow-up period), adjusting for all other variables. This was hypothesized based on previous
literature, in which patients who were classified as “frequent attenders” experienced significantly
higher rates of subsequent health care use 63-65. A systematic review of frequent attenders by
Vedsted and Christensen (2005) concluded that one-third of frequent attenders continued to be
high users of health care resources, such as through increased visits to clinics and increased
hospitalizations during the following year 128. Our findings showed an inconsistent relationship
between the previous care-seeking frequency of a patient and their subsequent health care use.
While a positive relationship was found with the number of visits in the year following the index
visit, adjusting for all other variables in the multivariable model (a 4% increase in the number of
subsequent visits), decreases were found with the number of referrals and the number of
laboratory tests and investigations (a 4% decrease for each outcome). Further interpretation of
these results will be presented later.

5.3. Objective Three: Differences in Health Care Utilization between Comparative Groups
The third objective assessed the differences in health care utilization patterns (that is the
number of subsequent visits, number of referrals, and the number of laboratory tests and
investigations) between the case patients and the comparison patients. The case and comparison
patients were matched on a 1:1 ratio, and these two patient groups were not significantly
different on the matched variables, including age and gender (as seen in Table 11). Furthermore,
these two patient groups were not statistically different in the patients’ number of previous and
co-occurring chronic and psychosocial morbidities (as seem in Table 11).
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Hypothesis 3: It was hypothesized that the fatigue symptom patients would experience
an increased number of subsequent visits, referrals, and investigations during the one year
follow-up period, in comparison to their matched, non-fatigue comparison patients. The fatigue
symptom patients were found to have 19% more subsequent in-office visits and 68% more
laboratory tests and investigations during the one year follow-up period, as compared to the other
symptom patients and adjusting for all other variables. However, there was no statistically
significant difference found between these two patient groups in the number of referrals received
during the following year.
There are a number of potential reasons for these findings. Firstly, these findings could be
true in that fatigue patients are significantly more likely to experience increased subsequent visits
and increased investigations as compared to other symptom patients. Secondly, although the case
and comparison patients were matched on a number of factors (age, sex, practice, provider, and
quarter of index visit date); differences in subsequent health care use may have been the result of
a variety of other factors, including variation in the burden of morbidity and differences in the
previous care-seeking frequencies among the patients. As was described in Table 11, the fatigue
symptom patients had significantly higher prevalence rates of previous and co-occurring nonchronic, non-psychosocial conditions, as well as significantly higher care-seeking frequencies or
visits during the preceding year leading to the index visit. However, even after adjusting for
these characteristics, the fatigue symptom patients still experienced a significantly higher number
of subsequent visits and subsequent laboratory tests and investigations. Thirdly, the case and
comparison patients may have also differed in the number of subsequent visits or investigations
because of differences in unmeasured factors influencing evaluated need by the providers (in that
the health care provider may have asked the fatigue symptom patients to come back for more
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follow-up visits or ordered more tests and investigations) or differences in perceived need among
the case and comparison patients (in that fatigue symptom patients may have perceived
themselves as having a greater burden of illness, and therefore came back for more follow-up
visits or demanded more tests and investigations). Although, these unmeasured and potential
factors did not seem to produce similar differences in the referral patterns between the fatigue
and non-fatigue patients.
Our results were not consistent with the Cathebras et al. study, which compared 93
fatigue patients with patients in the remaining clinic sample 39. Despite higher levels of somatic
and emotional distress among the fatigue patients, these patients were not significantly different
in the number of visits to their primary care provider during the one year follow-up period, as
compared to the other clinic patients. However, as the evaluation of health care use was done
through a follow-up survey, the validity of these results may have been compromised by: 1) selfreport measures which may have been systematically answered differently by fatigue patients
versus other patients; and/or 2) an attrition rate of 28% among the initial fatigue patient group (as
compared to the attrition rate of 21% for the total clinic population). One strength of the current
study was the use of an electronic medical record which consistently recorded each patient’s
visits to the primary care provider, which eliminated the potential influence of recall bias or the
underestimation of the number of visits by patients due to the bias of reporting socially
acceptable answers, both of which are possible in self-reported measures.
In the study conducted by Ridsdale et al. (1994), physicians recruited 220 patients (aged
sixteen years and older) who had presented to their offices with fatigue over a one year period 68.
These patients were then matched (by age, sex, physician, and practice) with a comparison group
of patients. This study found that patients who had presented with self-reported fatigue attended
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the primary care practice significantly more frequently than the comparison group in the six
months after entry into the study. Patients with fatigue visited their primary care provider an
average of 4.2 times (95% CI=3.7 - 4.6) compared with 1.6 visits (95% CI=1.3 - 1.9) for patients
in the comparison group 68. These results were generally similar to the current study in that the
fatigue patients had a significantly increased number of subsequent visits as compared to the
comparison group (an average of 6.2 visits in a six month follow-up period and an average of 5.3
visits in a six month follow-up period, respectively). Although our study found similar
differences between patient groups, our patients’ number of subsequent visits was slightly higher
with an average of 6.2 visits (as compared to an average of 4.2 visits) during a six month followup period. Ridsdale et al. concluded that the frequency of subsequent visits in the fatigued patient
group could not be related to the duration or severity of the fatigue symptoms alone, but that
fatigue patients were more likely to attend more frequently when also reporting symptoms of
psychological distress, a correlation that has been noted in a number of previous studies 68.
However, this was not reflected in the current study as the case and comparison patients
experienced similar levels of psychosocial morbidity at baseline. Previous studies examining
differences in the number of investigations and referrals between fatigue and non-fatigued
patient groups were not found in the literature for comparison, and consequently the current
study will provide an important contribution in this area.

5.4. Summary and Interpretation of Findings
Two elements of our findings were chosen for further interpretation. Some of these
findings may provide contributions to the existing fatigue literature and therefore require further
interpretation and assessment.
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The first key finding was a result of our comparative study research design, and
distinguished differences in health services use by fatigue symptom patients, when compared to
other symptom patients. More specifically, the previously un-researched outcome of the number
of laboratory tests and investigations was found to be a resource that fatigue symptom patients
utilized 68% more frequently than the comparison patients, which designates a topic that is
worthy of more attention. This finding may potentially highlight the reality that symptoms of
fatigue, unlike other symptoms, are symptoms of ill health that both providers and patients want
to explain and investigate, instead of using the “wait and see” approach. Additionally, as fatigue
symptom patients experienced a higher frequency of subsequent visits, perhaps the need to
explain and investigate the fatigue occurrence was increased or more substantiated. These
statistically significant differences between our fatigue and non-fatigue symptom patients justify
the current study and emphasize the importance of future research and clinical focus on this
particular group of patients.
The second key series of findings was a result of our examination of fatigue symptom
patients’ health care use patterns. The fatigue symptom patients had substantial levels of
referrals, with almost 65% of these patients experiencing at least one referral during the one year
follow-up period. Possible reasons for these high rates of referrals may be because primary care
providers do not feel comfortable dealing with patients presenting with fatigue (whether as a
primary or secondary complaint) and the complex of associated conditions presented with the
fatigue symptom; the providers may receive pressure from the patients to provide a referral; or
the natural history of the patient’s health conditions required specialized care. Furthermore, male
fatigue symptom patients were almost 60% more likely to receive a referral, as compared to
female fatigue patients. This may have been because the female patient’s fatigue and associated

99
conditions were less severe or were assumed to be less severe by the provider. Although not
examined among fatigue patients; women experiencing cardiovascular symptoms have historically
been shown to be treated differently than men in terms of receiving adequate diagnosis or
treatment 136. Further research could focus on these potential distinctions using larger sample
sizes and subgroup analyses.
As well, fatigue symptom patients who were experiencing other previous and cooccurring conditions (non-chronic and non-psychosocial) were significantly more likely to be
referred for specialized care. However, similar significant relationships were not found for
referrals of fatigue patients who were experiencing concomitant chronic or psychosocial
conditions. These findings could indicate that fatigue presentation in a chronically ill patient may
have been confidently handled by the primary care provider, but fatigue presentation
accompanied by non-chronic conditions warranted a more concerted search for diagnosis
through referral to a specialist, instead of management by the primary care provider.
Patients who were considered frequent attenders were less likely to be referred and also
to receive laboratory tests and investigations. A possible interpretation of these findings may be
that although frequent attenders to primary care providers remained frequent attenders in the
following year, these patients were more likely to be cared for within the primary care office
setting and not referred or sent for laboratory tests or investigations. This may be because the
primary care providers were less likely to refer or investigate for patients who were deemed
frequent attenders. On the other hand, the initiation of a referral or investigation was possibly
more likely for patients who were previously low or infrequent care-seekers, and who were
perhaps less well known by their provider and whose presentation of fatigue symptoms required
more extensive exploration or investigation over the following year.
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Due to the fact that these data were the first study in twenty years to examine the
presence of fatigue in primary care in Canada, and given the various strengths of this research (as
discussed in a following section), our overall findings highlight the need for further research and
further understanding of these patients and their influence on the Canadian health care system.

5.5. Generalizability of Results
5.5.1. Comparison of Included and Excluded Fatigue Symptom Patients
Due to the inclusion criteria (of a sufficient one year run-in and follow-up period, as well
as a suitable index visit), 177 or 64% of patients who had presented with the RFE of fatigue for
at least one in-office visit during the data collection period were excluded from the analysis.
However, there were no significant differences between the fatigue symptom patients who were
included in the analysis and the fatigue symptom patients who were excluded. The mean age of
the included patients was approximately 66.0 years, versus 63.3 years for excluded patients (not
statistically significant, p=0.304). The proportion of male and female patients was also similar
between the included and excluded groups, with proportion of female patients being 68.0% and
63.3%, respectively (not statistically significant, p=0.430). A summary of these results can be
found in Appendix L.

5.5.2. Comparison of DELPHI ICPC Population and Canadian Census Population
When compared to the 2011 Canadian census population, the DELPHI ICPC patient
population was found to be older and with a higher proportion of females (as can be seen in
Appendix M) 129. The median age of the DELPHI ICPC population was 56 years, while the
median age of the 2011 Canadian census population was 40.6 years. Furthermore, 57% of the
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ICPC population was female, compared to 51% of the census population. These differences do
not indicate that the DELPHI ICPC population was different from the Canadian population, as
the ICPC population represented a random sample of individuals who sought care from their
primary care provider. Females and older individuals have been consistently shown in the
literature to seek care more often 9, 62-65, 128, they would therefore have been more likely to be
included in the overall DELPHI population, and subsequently in our case and comparison patient
samples. Regardless, inferences made beyond the Southwestern Ontario population must be done
carefully.

5.6. Strengths of Research
This study was the first in twenty years to describe the presence and characteristics of
fatigue symptom patients within the context of the Canadian health care system. This study also
made a valuable contribution to the limited body of research that has worked to characterize
symptom patients and their subsequent health care use patterns using an electronic medical
record, and more specifically the ICPC system. As electronic medical records become more
ubiquitous in health care delivery, particularly in primary health care delivery, research using
these rich sources of data will become increasingly important.
The use of the ICPC system to identify fatigue symptom patients was a particularly
unique facet of the current Canadian research. This allowed the identification of fatigue symptom
patients recorded from the patient’s reason for the visit, which did not require a health care to
discern the symptom, but only to record it. Moreover, the ICPC system enabled the
characterization of the symptom patients’ level of co-occurring morbidity (by counting and
categorizing the End of Visit codes over the one year run-in period); this created a more
complete picture of a patient’s overall health and measured a potentially significant influence on
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a patient’s level of health care use. Finally, this study included patients on the wide spectrum of
fatigue, and was not focused only on chronic fatigue syndrome patients or severely fatigued
patients, which has been identified as a weakness in past studies that have focused on these
highly selected subgroups of fatigue sufferers 15.
The current study also examined three dimensions of health care use: number of in-office
visits, number of referrals to specialists, and number of investigations. Previous literature that
has focused on fatigue patients and their health care resource use has had a limited measurement
of usage; typically focusing on primary care visits, visits to alternative health care providers, and
number of hospitalizations. Although this study was not able to capture visits to alternative
health care providers or use of hospital services, it aimed to capture three dimensions of primary
health care system use: visits to primary care providers, visits to secondary and tertiary care
clinics, and use of investigative resources. The EMR also allowed for a longitudinal assessment
of these variables during the one year follow-up period. In a recent systematic review of fatigue
studies by Nijrolder et al. (2008), it was noted that most studies did have an approximate one
year follow-up period; however only one measurement (such as a follow-up questionnaire or
survey) was used to capture information after the baseline assessment 49.

5.7. Limitations of Research
A potential limitation of the current study and its use of EMRs was that we were unable
to measure the severity of symptoms when capturing a patient’s level of morbidity. Although
including the level of severity of each condition would have given a more in-depth picture of the
health of our case and comparison patients, this measurement was not available within our data
source. Instead, a crude number of recorded morbidities were captured. However, as reported by
Sha et al. (2005), the total symptom or morbidity count does, at minimum, provide an important
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proxy for severity of illness and is still considered a valuable tool in measuring a patient’s level
of health, particularly if scales of severity have not yet been incorporated into the EMR 2.
Another limitation of using an EMR is that we were unable to capture visits to alternative
or allied health professionals. As has been shown in previous research, fatigue symptom patients
tended to use a large amount of complementary and alternative therapies in order to manage or
treat their symptoms 24. We were also unable to capture details of the socioeconomic status of
each of the included patients, which would have provided more patient- or context-level
variables and could have accounted for important contributing factors to the patients’ health and
health care utilization patterns.
As was mentioned previously, assessing the validity and completeness of EMR-derived
data can be challenging. Although evidence from previous research was used to broadly assess
the completeness of the data used for this study, we were unable to differentiate between truly
missing data (when a provider failed to record existing information into the EMR) and a zero
count (when a patient did not have a co-occurring morbidity, subsequent referral or subsequent
investigation). However, it was assumed that the missingness within the data source occurred at
random, as we had no reason to believe that the participating providers preferentially recorded
data based on the individual patient characteristics.
In a similar sense, the dependent variables (measuring the number of referrals and the
number of laboratory tests and investigations) could not capture whether the patient truly visited
a specialist after being referred or had the laboratory test or investigation done after it was
ordered by the provider. Instead, these variables only captured the referrals and investigations
that were recorded in the EMR during the follow-up period. Although this may have resulted, in
this case, in an overestimate of the actual health care use by our patient groups, a review of the
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literature on the validity of EMR-derived data indicated that these variables were sufficient in
meeting the objective of this research.

5.8. Policy and Practice Implications
Symptoms are the principal reason for clinic visits in approximately half of all outpatient
encounters 31. Patients with complex and multiple concurrent problems are now the norm rather
than the exception in primary care patients 130. In fact, work by Fortin et al. (2005) determined
that approximately 90% of patients in Canadian family practices were suffering from more than
one chronic condition and as many as 50% of patient had five or more concurrent chronic
conditions 131. The present study also found high levels of co-occurring morbidities with 88.4%,
52.4%, and 91.3% of fatigue symptom patients experiencing one or more chronic, psychosocial
or non-chronic, non-psychosocial co-occurring conditions, respectively. Although the prevalence
of multiple health conditions has been shown to increase with age in both men and women,
multimorbidity can no longer be perceived as just an issue for older adults 132. Despite advances
in medical care and public health initiatives, a growing proportion of individuals suffer from
complex multimorbidity 133.
Currently, health care providers have limited guidance or evidence as to how to approach
care decisions for patients suffering from multidimensional conditions 132. Establishing a more
comprehensive understanding of how best to deliver care and how best to design the health care
system for these patients may lead to significant improvements in quality of life, utilization of
health care, patient safety, patient satisfaction, morbidity, and mortality 130, 132, 134. A recent study
by Glynn et al. (2011) found that health care utilization was significantly increased among
patients with multimorbidity 134. Regarding practice implications, communicating the prevalence
of the symptom of fatigue found by this study to clinicians would reinforce the fact that symptom
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patients represent a significant population within their practice. Furthermore, the majority of the
fatigue patients were not just experiencing fatigue alone, but were suffering from multiple chronic,
concomitant morbidities. Although this study evaluated only three dimensions of health services
use, clinicians would be interested to note that fatigue patients had high levels of health care usage.
A specific recommendation from the current study is to improve the development of
clinical guidelines, particularly fatigue guidelines, in order to promote the provision of high
quality care that meets the needs of patients suffering from multidimensional or multimorbid
conditions. This could be done by encouraging providers to practice patient-centred care, which
has been viewed as essential approach when dealing with patients with multimorbidity 130, 132. In
a general sense, this patient-centred approach focuses on assessing the complex needs of the
patients, as well as developing and strengthening the patient-provider relationship 132, 135. The
understanding of a “typical” patient with the symptom of fatigue will help to reduce the amount
of uncertainty among health professionals, and it will help to inform improved health policy and
clinical guideline development into the future.

5.9. Future Research
Future research can continue to form an understanding of symptom patients in primary
care through longer data collection periods. Electronic medical records are a valuable source of
longitudinal data, in which multiple dimensions of health and health care use can be recorded
into one comprehensive database. The present study was longer than many previous studies, with
a one year run-in and a one year follow-up period. However, care over time is key in the
management of patients in primary care. Including more years of observation would allow for
the study of recurrent visits for the symptom of fatigue, with sufficient run-in and follow-up
periods and adequate sample sizes. This would enable an extended exploration of the impact of
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recurrent symptom presentation and the complex of patient morbidity on subsequent health care
utilization.
Future research could also incorporate more patient- and context-level characteristics as
possible predictors of health care utilization. The current data that is available from EMR
databases does not allow for the exploration of more comprehensive patient- or context-level
details. This would require an addition of qualitative data, which could be collected and recorded
from brief surveys or interviews conducted during the encounter. For example, these approaches
could collect data on patient socioeconomic status, education level, employment status, ethnicity,
and immigrant status, given our diverse and multiethnic population in Ontario and Canada. The
outcomes that could be evaluated with these added characteristics could include the patient’s
perception and satisfaction with care they have received or a patient narrative detailing their
experiences of their constellation of morbidity and symptoms.
Finally, future work assessing the validity and quality of EMR-derived data is essential.
As growing volumes of data are routinely being recorded, ensuring consistent, complete and
accurate data recording increases in importance. A greater focus on the effects of feedback,
incentives and evidence-based guidelines in improving data recording by health care
professionals, as well as the development of data validation measures in order to establish
appropriate levels of data quality within an EMR database, are all areas of opportunity for future
studies.

5.10. Conclusion
Fatigue is a common issue in primary care and has been shown to pose a significant
financial burden on the health care system and the broader community. This study provided a
current characterization of fatigue symptom patients, and their subsequent health care use, in
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comparison to patients who have presented to a primary care provider with other symptoms and
in the context of the Canadian health care system. This was the first Canadian study to identify
symptom patients and to capture their morbidity characteristics through an EMR database, and
more specifically through the primary care-focused coding of the ICPC system. This study
explored the determinants of health care use and found that fatigue symptom patients
experienced higher subsequent visits and investigations over a one year follow-up period, when
compared to other symptom patients.
Based on the results of this study, primary care providers, specifically family physicians
and nurse practitioners, as well as policy makers could dedicate more attention to the care of
symptom patients. For our fatigue symptom patients, the most important findings that were
supported by previous literature were a consistently high proportion of female patients; a large
number of co-occurring conditions; and a significant amount of overall health care use. New
findings from the current study demonstrated that these patients had an older average age as
compared to previous studies; that the level of chronic or psychosocial morbidity was in fact not
significantly related to subsequent health care use; that the fatigue symptom patients experienced
significant numbers of referrals, particularly males and patients with non-chronic conditions; and
that fatigue symptom patients had more subsequent visits and laboratory tests and investigations,
in comparison to other symptom patients. Managing non-specific symptoms will continue to
present challenges for primary care providers, but particularly in the case of fatigue, a growing
understanding of these patients will help to provide increased guidance for providers and
improved management of symptom patients into the future.
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APPENDICES
Appendix A: RFE Symptom Codes Used to Identify Case and Comparison Patients
ICPC Code
A01
A02
A03
A04
A05
A06
A07
A08
A09
A10
A11
A13
A16
A18
A20
A21
A23
A25
A26
A27
A28
A29
B02
B04
B25
B26
B27
B28
B29
D01
D02
D03
D04
D05
D06
D07

ICPC Code Description
Pain general/multiple sites
Chills
Fever
Weakness/tiredness general*
Feeling ill
Fainting/syncope
Coma
Swelling
Sweating problem
Bleeding/haemorrhage NOS
Chest pain NOS
Concern about/fear of medical treatment
Irritable infant
Concern about appearance
Euthanasia request/discussion
Risk factor for malignancy
Risk factor NOS
Fear of death/dying
Fear of cancer NOS
Fear of other disease NOS
Limited function/disability NOS
General symptom/complaint other
Lymph gland(s) enlarged/painful
Blood symptom/complaint
Fear of AIDS/HIV
Fear of cancer blood/lymph
Fear of blood/lymph disease other
Limited function/disability (B)
Lymph/immune mechanism symptom/complaint other
Abdominal pain/cramps general
Abdominal pain epigastric
Heartburn
Rectal/anal pain
Perianal itching
Abdominal pain localized other
Dyspepsia/indigestion
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ICPC Code
D08
D09
D10
D11
D12
D13
D14
D15
D16
D17
D18
D19
D20
D21
D23
D24
D25
D26
D27
D28
D29
F01
F02
F03
F04
F05
F13
F14
F15
F16
F17
F18
F27
F28
F29
H01
H02
H03
H04
H05

ICPC Code Description
Flatulence/gas/belching
Nausea
Vomiting
Diarrhoea
Constipation
Jaundice
Haematemesis/vomiting blood
Melaena
Rectal bleeding
Incontinence of bowel
Change in faeces/bowel movements
Teeth/gum symptom/complaint
Mouth/tongue/lip symptom/complaint
Swallowing problem
Hepatomegaly
Abdominal mass NOS
Abdominal distension
Fear of cancer of digestive system
Fear of digestive disease other
Limited function/disability (D)
Digestive symptom/complaint other
Eye pain
Red eye
Eye discharge
Visual floaters/spots
Visual disturbance other
Eye sensation abnormal
Eye movements abnormal
Eye appearance abnormal
Eyelid symptom/complaint
Glasses symptom/complaint
Contact lens symptom/complaint
Fear of eye disease
Limited function/disability (F)
Eye symptom/complaint other
Ear pain/earache
Hearing complaint
Tinnitus, ringing/buzzing ear
Ear discharge
Bleeding ear
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ICPC Code
H13
H15
H27
H28
H29
K01
K02
K03
K04
K05
K06
K07
K22
K24
K25
K27
K28
K29
L01
L02
L03
L04
L05
L07
L08
L09
L10
L11
L12
L13
L14
L15
L16
L17
L18
L19
L20
L26
L27
L28

ICPC Code Description
Plugged feeling ear
Concern with appearance of ears
Fear of ear disease
Limited function/disability (H)
Ear symptom/complaint other
Heart pain
Pressure/tightness of heart
Cardiovascular pain NOS
Palpitations/awareness of heart
Irregular heartbeat other
Prominent veins
Swollen ankles/oedema
Risk factor for cardiovascular disease
Fear of heart disease
Fear of hypertension
Fear of cardiovascular disease other
Limited function/disability (K)
Cardiovascular symptom/complaint other
Neck symptom/complaint
Back symptom/complaint
Low back symptom/complaint
Chest symptom/complaint
Flank/axilla symptom/complaint
Jaw symptom/complaint
Shoulder symptom/complaint
Arm symptom/complaint
Elbow symptom/complaint
Wrist symptom/complaint
Hand/finger symptom/complaint
Hip symptom/complaint
Leg/thigh symptom/complaint
Knee symptom/complaint
Ankle symptom/complaint
Foot/toe symptom/complaint
Muscle pain
Muscle symptom/complaint NOS
Joint symptom/complaint NOS
Fear of cancer musculoskeletal
Fear of musculoskeletal disease other
Limited function/disability (L)
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ICPC Code
L29
N01
N03
N04
N05
N06
N07
N08
N16
N17
N18
N19
N26
N27
N28
N29
P01
P02
P03
P04
P05
P06
P07
P08
P09
P10
P11
P12
P13
P15
P16
P17
P18
P19
P20
P22
P23
P24
P25
P27

ICPC Code Description
Musculoskeletal symptom/complaint other
Headache
Pain face
Restless legs
Tingling fingers/feet/toes
Sensation disturbance other
Convulsion/seizure
Abnormal involuntary movements
Disturbance of smell/taste
Vertigo/dizziness
Paralysis/weakness
Speech disorder
Fear of cancer of neurological system
Fear of neurological disease other
Limited function/disability (N)
Neurological symptom/complaint other
Feeling anxious/nervous/tense
Acute stress reaction
Feeling depressed
Feeling/behaving irritable/angry
Senility, feeling/behaving old
Sleep disturbance
Sexual desire reduced
Sexual fulfillment reduced
Sexual preference concern
Stammering/stuttering/tic
Eating problem in child
Bedwetting/enuresis
Encopresis/bowel training problem
Chronic alcohol abuse
Acute alcohol abuse
Tobacco abuse
Medication abuse
Drug abuse
Memory disturbance
Child behaviour symptom/complaint
Adolescent behaviour symptom/complaint
Specific learning problem
Phase of life problem adult
Fear of mental disorder
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ICPC Code
P28
P29
R01
R02
R03
R04
R05
R06
R07
R08
R09
R21
R23
R24
R25
R26
R27
R28
R29
S01
S02
S03
S04
S05
S06
S07
S08
S09
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21

ICPC Code Description
Limited function/disability (P)
Psychological symptom/complaint other
Pain respiratory system
Shortness of breath/dyspnoea
Wheezing
Breathing problem other
Cough
Nose bleed/epistaxis
Sneezing/nasal congestion
Nose symptom/complaint other
Sinus symptom/complaint
Throat symptom/complaint
Voice symptom/complaint
Haemoptysis
Sputum/phlegm abnormal
Fear of cancer of respiratory system
Fear of respiratory disease other
Limited function/disability (R)
Respiratory symptom/complaint other
Pain/tenderness of skin
Pruritus
Warts
Lump/swelling localized
Lumps/swellings generalized
Rash localized
Rash generalized
Skin colour change
Infected finger/toe
Boil/carbuncle
Skin infection post-traumatic
Insect bite/sting
Animal/human bite
Burn/scald
Foreign body in skin
Bruise/contusion
Abrasion/scratch/blister
Laceration/cut
Skin injury other
Corn/callosity
Skin texture symptom/complaint
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ICPC Code
S22
S23
S24
S26
S27
S28
S29
T01
T02
T03
T04
T05
T07
T08
T10
T11
T26
T27
T28
T29
U01
U02
U04
U05
U06
U07
U08
U13
U14
U26
U27
U28
U29
W01
W02
W03
W05
W10
W11

ICPC Code Description
Nail symptom/complaint
Hair loss/baldness
Hair/scalp symptom/complaint other
Fear of cancer of skin
Fear of skin disease other
Limited function/disability (S)
Skin symptom/complaint other
Excessive thirst
Excessive appetite
Loss of appetite
Feeding problem of infant/child
Feeding problem of adult
Weight gain
Weight loss
Growth delay
Dehydration
Fear of cancer of endocrine system
Fear of endocrine/metabolic disease other
Limited function/disability (T)
Endocrine/metabolic/nutritional symptom/complaint other
Dysuria/painful urination
Urinary frequency/urgency
Incontinence urine
Urination problems other
Haematuria
Urine symptom/complaint other
Urinary retention
Bladder symptom/complaint other
Kidney symptom/complaint
Fear of cancer of urinary system
Fear of urinary disease other
Limited function/disability (U)
Urinary symptom/complaint other
Question of pregnancy
Fear of pregnancy
Antepartum bleeding
Pregnancy vomiting/nausea
Contraception postcoital
Contraception oral
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ICPC Code
W12
W13
W14
W15
W17
W18
W19
W21
W27
W28
W29
X01
X02
X03
X04
X05
X06
X07
X08
X09
X10
X11
X12
X13
X14
X15
X16
X17
X18
X19
X20
X21
X22
X23
X24
X25
X26
X27
X28

ICPC Code Description
Contraception intrauterine
Sterilization female
Contraception female other
Infertility/subfertility female
Post-partum bleeding
Post-partum symptom/complaint other
Breast/lactation symptom/complaint
Concern about body image related to pregnancy
Fear of complications of pregnancy
Limited function/disability (W)
Pregnancy symptom/complaint other
Genital pain female
Menstrual pain
Intermenstrual pain
Painful intercourse female
Menstruation absent/scanty
Menstruation excessive
Menstruation irregular/frequent
Intermenstrual bleeding
Premenstrual symptom/complaint
Postponement of menstruation
Menopausal symptom/complaint
Postmenopausal bleeding
Postcoital bleeding
Vaginal discharge
Vaginal symptom/complaint other
Vulval symptom/complaint
Pelvis symptom/complaint female
Breast pain female
Breast lump/mass female
Nipple symptom/complaint female
Breast symptom/complaint female other
Concern about breast appearance female
Fear of sexually transmitted disease female
Fear of sexual dysfunction female
Fear of genital cancer female
Fear of breast cancer female
Fear of genital/breast disease female other
Limited function/disability (X)

130
ICPC Code
X29
Y01
Y02
Y03
Y04
Y05
Y06
Y07
Y08
Y10
Y13
Y14
Y16
Y24
Y25
Y26
Y27
Y28
Y29
Z01
Z02
Z03
Z04
Z05
Z06
Z07
Z08
Z09
Z10
Z11
Z12
Z13
Z14
Z15
Z16
Z18
Z19
Z20
Z21
Z22

ICPC Code Description
Genital symptom/complaint female other
Pain in penis
Pain in testis/scrotum
Urethral discharge male
Penis symptom/complaint other
Scrotum/testis symptom/complaint other
Prostate symptom/complaint
Impotence NOS
Sexual function symptom/complaint male
Infertility/subfertility male
Sterilization male
Family planning male other
Breast symptom/complaint male
Fear of sexual dysfunction male
Fear of sexually transmitted disease male
Fear of genital cancer male
Fear of genital disease male other
Limited function/disability (Y)
Genital symptom/complaint male other
Poverty/financial problem
Food/water problem
Housing/neighbourhood problem
Social cultural problem
Work problem
Unemployment problem
Education problem
Social welfare problem
Legal problem
Health care system problem
Compliance/being ill problem
Relationship problem with partner
Partner behaviour problem
Partner illness problem
Loss/death of partner problem
Relationship problem with child
Illness problem with child
Loss/death of child problem
Relationship problem parent/family
Behaviour problem parent/family
Illness problem parent/family
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ICPC Code
Z23
Z24
Z25
Z27
Z28
Z29

ICPC Code Description
Loss/death of parent/family member problem
Relationship problem friend
Assault/harmful event problem
Fear of social problem
Limited function/disability (Z)
Social problem NOS

*Indicates symptom code used to identify case patients only
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Appendix B: Choice of Comparison Group
In determining the most suitable comparison group for this study, many options were
considered and their advantages and disadvantages were evaluated. This appendix describes the
two main structural options that were considered (multiple comparison groups or multiple case
groups) and the reasoning as to why they were considered and ultimately not chosen.
Establishing an appropriate comparison group is essential in the validity of a casecomparison study. It was determined early on that creating a similar structure around the date
and “type” (incident) of visit for the comparison patients in relation to the case patients was
important. Ensuring a sufficient one year run-in period and a sufficient one year follow-up period
around the comparison patient’s index date was also essential, in order to measure independent
and dependent variables consistently. Based on these basic decisions, two main structural options
were examined.
1a) The first option considered was organized into four comparison groups and one case
group, with each comparison group being comprised of the most common symptom patients.
This method of comparison selection was based on the goal of comparing health care utilization
patterns of the fatigue symptom patients to other symptom patients in the database. As well,
choosing the top four RFE symptom codes in the database was proposed in order to ensure
sufficient sample size numbers, particularly for a matched analysis. To be specific, the first
comparison group would consist of an equal mix of the four most common symptoms presented
in the ICPC database: 25% cough symptom patients (RFE of R05), 25% back pain symptom
patients (RFE of L02), 25% knee pain symptom patients (RFE of L15) and 25% shoulder pain
symptom patients (RFE of L08); the second comparison group would consist of 100% cough
patients (the most common symptom in the ICPC database); the third comparison group would
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consist of 100% back pain patients (the second most common symptom in the ICPC database);
and the fourth comparison group would consist of 100% knee pain patients (the third most
common symptom in the ICPC database). Each of the comparison groups would be mutually
exclusive, and each included comparison patient would be identified as having a visit for one of
the four main comparison symptoms. However, the justification as to why it was important to
compare the health care utilization patterns of fatigue symptom patients to each of the four
symptom groups could not be substantiated nor was it the true objective of this study.
1b) Building off of the first option, the next consideration was composed of two
comparison groups and one case group. This method would aim to compare health care
utilization patterns of the fatigue symptom patients to two significant symptom groups from the
ICPC population: musculoskeletal symptom patients and psychological symptom patients. In this
option, the first comparison group would consist of patients with musculoskeletal symptoms
(symptom codes from chapter “L”), while the second comparison group would consist of patients
with non-musculoskeletal symptoms (symptom codes from all other chapters). It was further
proposed that the non-musculoskeletal symptom patient group should be replaced with a
psychological symptom patient group (symptom codes from chapter “P”). However,
musculoskeletal symptom and psychological symptom patients have not been previously
established as high or low users of health care resources within this database, therefore the
interpretation of any potential findings was not well supported within this proposed structure.
2) The second option was composed of having three case groups in comparison to one
large comparison group consisting of all other ICPC patients. This approach would aim to
establish how fatigue symptom patients, musculoskeletal symptom patients, and psychological
symptom patients compare to the typical patient population in terms of their health care
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utilization. This method was seen as an opportunity to create a “theoretical yard stick” of health
care utilization, in which different symptom groups could be ranked as “higher users” or “lower
users” of health care resources in comparison to the “typical” or general patient population. This
approach was deemed as ultimately too ambitious to complete in the thesis timeframe, as it
would require not only literature reviews on the three symptom groups (fatigue, musculoskeletal,
and psychological symptoms presented in primary care), but also separate descriptive and
analytic analyses. Although this was considered a plausible and potentially meaningful approach,
it was decided to be more realistic to focus on fatigue symptom patients for the current study,
with one comparison group that consisted of all other symptom patients in the ICPC database.
Consequently, the final proposed option consisted of one comparison group (composed of
all remaining patients in the ICPC database, with an index visit for a non-fatigue symptom) and
one case group (composed of all of the fatigue symptom patients with an index visit for fatigue).
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Appendix C: List of Non-Symptom Codes Excluded in the Comparison Group
ICPC Rubric
_30
_31
_32
_33
_34
_35
_36
_37
_38
_39
_40
_41
_42
_43
_44
_45
_46
_47
_48
_49
_50
_51
_52
_53
_54
_55
_56
_57
_58
_59
_60
_61
_62
_63
_64
_65
_66
_67

ICPC Rubric Description
Medical examination/health evaluation complete
Medical examination/health evaluation partial
Sensitivity test
Microbiological/immunological test
Blood test
Urine test
Faeces test
Histological/exfoliative cytology
Other laboratory test NEC
Physical function test
Diagnostic endoscopy
Diagnostic radiology/imaging
Electrical tracing
Other diagnostic procedure
Preventive immunization/medication
Observation/health education/advice/diet
Consultation with primary care provider
Consultation with specialist
Clarification/discussion of patient's RFE/demand
Other preventive procedure
Medication/prescription/renewal/injection
Incision/drainage/flushing/aspiration/removal body fluid
Excision/removal tissue/biopsy/destruction/debridement/cauterization
Instrumentation/catheterization/intubation/dilation
Repair/fixation-suture/cast/prosthetic device (apply/remove)
Local injection/infiltration
Dressing/pressure/compression/tamponade
Physical medicine/rehabilitation
Therapeutic counseling/listening
Other therapeutic procedure/minor surgery NEC
Result test/procedure
Result examination/test/record/letter from other provider
Administrative procedure
Follow-up encounter unspecified
Encounter/problem initiated by provider
Encounter/problem initiated by other than patient/provider
Referral to other provider/nurse/therapist/social worker
Referral to physician/specialist/clinic/hospital
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ICPC Rubric
_68
_69
ICPC Code
A70
A71
A72
A73
A74
A75
A76
A77
A78
A79
A80
A81
A82
A84
A85
A86
A87
A88
A89
A90
A91
A92
A93
A94
A95
A96
A97
A98
A99
B70
B71
B72
B73
B74
B75
B76

ICPC Rubric Description
Other referral NEC
Other reason for encounter NEC
ICPC Code Description
Tuberculosis
Measles
Chickenpox
Malaria
Rubella
Infectious mononucleosis
Viral exanthem other
Viral disease other/NOS
Infectious disease other/NOS
Malignancy NOS
Trauma/injury NOS
Multiple trauma/injuries
Secondary effect of trauma
Poisoning by medical agent
Adverse effect medical agent
Toxic effect non-medicinal substance
Complication of medical treatment
Adverse effect physical factor
Effect prosthetic device
Congenital anomaly NOS/multiple
Abnormal result investigation NOS
Allergy/allergic reaction NOS
Premature newborn
Perinatal morbidity other
Perinatal mortality
Death
No disease
Health maintenance/preventive medicine
Disease/condition of unspecified nature/site
Lymphadenitis acute
Lymphadenitis chronic/non-specific
Hodgkin's disease/lymphoma
Leukaemia
Malignant neoplasm blood other
Neoplasm blood benign/unspecified
Ruptured spleen traumatic
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ICPC Code
B77
B78
B79
B80
B81
B82
B83
B84
B87
B90
B99
D70
D71
D72
D73
D74
D75
D76
D77
D78
D79
D80
D81
D82
D83
D84
D85
D86
D87
D88
D89
D90
D91
D92
D93
D94
D95
D96
D97
D98

ICPC Code Description
Injury blood/lymph/spleen other
Hereditary haemolytic anaemia
Congenital anomaly blood/lymph other
Iron deficiency anaemia
Anaemia vit B12/folate deficiency
Anaemia other/unspecified
Purpura/coagulation defect
Unexplained abnormal white cells
Splenomegaly
HIV-infection/AIDS
Blood/lymph/spleen disease other
Gastrointestinal infection
Mumps
Viral hepatitis
Gastroenteritis presumed infection
Malignant neoplasm stomach
Malignant neoplasm colon/rectum
Malignant neoplasm pancreas
Malignant digestive neoplasm other/NOS
Neoplasm digestive system benign/unspecified
Foreign body digestive system
Injury digestive system other
Congenital anomaly digestive system
Teeth/gum disease
Mouth/tongue/lip disease
Oesophagus disease
Duodenal ulcer
Peptic ulcer other
Stomach function disorder
Appendicitis
Inguinal hernia
Hiatus hernia
Abdominal hernia other
Diverticular disease
Irritable bowel syndrome
Chronic enteritis/ulcerative colitis
Anal fissure/perianal abscess
Worms/other parasites
Liver disease NOS
Cholecystitis/cholelithiasis

138
ICPC Code
D99
F70
F71
F72
F73
F74
F75
F76
F79
F80
F81
F82
F83
F84
F85
F86
F91
F92
F93
F94
F95
F99
H70
H71
H72
H73
H74
H75
H76
H77
H78
H79
H80
H81
H82
H83
H84
H85
H86
H99

ICPC Code Description
Disease digestive system other
Conjunctivitis infectious
Conjunctivitis allergic
Blepharitis/stye/chalazion
Eye infection/inflammation other
Neoplasm of eye/adnexa
Contusion/haemorrhage eye
Foreign body in eye
Injury eye other
Blocked lacrimal duct of infant
Congenital anomaly eye other
Detached retina
Retinopathy
Macular degeneration
Corneal ulcer
Trachoma
Refractive error
Cataract
Glaucoma
Blindness
Strabismus
Eye/adnexa disease other
Otitis externa
Acute otitis media/myringitis
Serous otitis media
Eustachian salpingitis
Chronic otitis media
Neoplasm of ear
Foreign body in ear
Perforation ear drum
Superficial injury of ear
Ear injury other
Congenital anomaly of ear
Excessive ear wax
Vertiginous syndrome
Otosclerosis
Presbyacusis
Acoustic trauma
Deafness
Ear/mastoid disease other
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ICPC Code
K70
K71
K72
K73
K74
K75
K76
K77
K78
K79
K80
K81
K82
K83
K84
K85
K86
K87
K88
K89
K90
K91
K92
K93
K94
K95
K96
K99
L70
L71
L72
L73
L74
L75
L76
L77
L78
L79
L80
L81

ICPC Code Description
Infection of circulatory system
Rheumatic fever/heart disease
Neoplasm cardiovascular
Congenital anomaly cardiovascular
Ischaemic heart disease with angina
Acute myocardial infarction
Ischaemic heart disease without angina
Heart failure
Atrial fibrillation/flutter
Paroxysmal tachycardia
Cardiac arrhythmia NOS
Heart/arterial murmur NOS
Pulmonary heart disease
Heart valve disease NOS
Heart disease other
Elevated blood pressure
Hypertension uncomplicated
Hypertension complicated
Postural hypotension
Transient cerebral ischaemia
Stroke/cerebrovascular accident
Cerebrovascular disease
Atherosclerosis/peripheral vascular disease
Pulmonary embolism
Phlebitis/thrombophlebitis
Varicose veins of leg
Haemorrhoids
Cardiovascular disease other
Infection of musculoskeletal system
Malignant neoplasm musculoskeletal
Fracture: radius/ulna
Fracture: tibia/fibula
Fracture: hand/foot bone
Fracture: femur
Fracture: other
Sprain/strain of ankle
Sprain/strain of knee
Sprain/strain of joint NOS
Dislocation/subluxation
Injury musculoskeletal NOS
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ICPC Code
L82
L83
L84
L85
L86
L87
L88
L89
L90
L91
L92
L93
L94
L95
L96
L97
L98
L99
N70
N71
N72
N73
N74
N75
N76
N79
N80
N81
N85
N86
N87
N88
N89
N90
N91
N92
N93
N94
N95
N99

ICPC Code Description
Congenital anomaly musculoskeletal
Neck syndrome
Back syndrome without radiating pain
Acquired deformity of spine
Back syndrome with radiating pain
Bursitis/tendinitis/synovitis NOS
Rheumatoid/seropositive arthritis
Osteoarthrosis of hip
Osteoarthrosis of knee
Osteoarthrosis other
Shoulder syndrome
Tennis elbow
Osteochondrosis
Osteoporosis
Acute internal damage knee
Neoplasm musculoskeletal benign/unspecified
Acquired deformity of limb
Musculoskeletal disease other
Poliomyelitis
Meningitis/encephalitis
Tetanus
Neurological infection other
Malignant neoplasm nervous system
Benign neoplasm nervous system
Neoplasm nervous system unspecified
Concussion
Head injury other
Injury nervous system other
Congenital anomaly neurological
Multiple sclerosis
Parkinsonism
Epilepsy
Migraine
Cluster headache
Facial paralysis/bell's palsy
Trigeminal neuralgia
Carpal tunnel syndrome
Peripheral neuritis/neuropathy
Tension headache
Neurological disease other
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ICPC Code
P70
P71
P72
P73
P74
P75
P76
P77
P78
P79
P80
P81
P82
P85
P86
P98
P99
R71
R72
R73
R74
R75
R76
R77
R78
R79
R80
R81
R82
R83
R84
R85
R86
R87
R88
R89
R90
R92
R95
R96

ICPC Code Description
Dementia
Organic psychosis other
Schizophrenia
Affective psychosis
Anxiety disorder/anxiety state
Somatization disorder
Depressive disorder
Suicide/suicide attempt
Neuraesthenia/surmenage
Phobia/compulsive disorder
Personality disorder
Hyperkinetic disorder
Post-traumatic stress disorder
Mental retardation
Anorexia nervosa/bulimia
Psychosis NOS/other
Psychological disorders other
Whooping cough
Strep throat
Boil/abscess nose
Upper respiratory infection acute
Sinusitis acute/chronic
Tonsillitis acute
Laryngitis/tracheitis acute
Acute bronchitis/bronchiolitis
Chronic bronchitis
Influenza
Pneumonia
Pleurisy/pleural effusion
Respiratory infection other
Malignant neoplasm bronchus/lung
Malignant neoplasm respiratory other
Benign neoplasm respiratory
Foreign body nose/larynx/bronchus
Injury respiratory other
Congenital anomaly respiratory
Hypertrophy tonsils/adenoids
Neoplasm respiratory unspecified
Chronic obstructive pulmonary disease
Asthma
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ICPC Code
R97
R98
R99
S70
S71
S72
S73
S74
S75
S76
S77
S78
S79
S80
S81
S82
S83
S84
S85
S86
S87
S88
S89
S90
S91
S92
S93
S94
S95
S96
S97
S98
S99
T70
T71
T72
T73
T78
T80
T81

ICPC Code Description
Allergic rhinitis
Hyperventilation syndrome
Respiratory disease other
Herpes zoster
Herpes simplex
Scabies/other acariasis
Pediculosis/skin infestation other
Dermatophytosis
Moniliasis/candidiasis skin
Skin infection other
Malignant neoplasm of skin
Lipoma
Neoplasm skin benign/unspecified
Solar keratosis/sunburn
Haemangioma/lymphangioma
Naevus/mole
Congenital skin anomaly other
Impetigo
Pilonidal cyst/fistula
Dermatitis seborrhoeic
Dermatitis/atopic eczema
Dermatitis contact/allergic
Diaper rash
Pityriasis rosea
Psoriasis
Sweat gland disease
Sebaceous cyst
Ingrown nail
Molluscum contagiosum
Acne
Chronic ulcer skin
Urticaria
Skin disease other
Endocrine infection
Malignant neoplasm thyroid
Benign neoplasm thyroid
Neoplasm endocrine other/unspecified
Thyroglossal duct/cyst
Congenital anomaly endocrine/metabolic
Goitre
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ICPC Code
T82
T83
T85
T86
T87
T89
T90
T91
T92
T93
T99
U70
U71
U72
U75
U76
U77
U78
U79
U80
U85
U88
U90
U95
U98
U99
W70
W71
W72
W73
W75
W76
W78
W79
W80
W81
W82
W83
W84
W85

ICPC Code Description
Obesity
Overweight
Hyperthyroidism/thyrotoxicosis
Hypothyroidism/myxoedema
Hypoglycaemia
Diabetes insulin dependent
Diabetes non-insulin dependent
Vitamin/nutritional deficiency
Gout
Lipid disorder
Endocrine/metabolic/nutritional disease other
Pyelonephritis/pyelitis
Cystitis/urinary infection other
Urethritis
Malignant neoplasm of kidney
Malignant neoplasm of bladder
Malignant neoplasm urinary other
Benign neoplasm urinary tract
Neoplasm urinary tract unspecified
Injury urinary tract
Congenital anomaly urinary tract
Glomerulonephritis/nephrosis
Orthostatic albuminuria/proteinuria
Urinary calculus
Abnormal urine test NOS
Urinary disease other
Puerperal infection/sepsis
Other infection complicating pregnancy/puerperium
Malignant neoplasm related to pregnancy
Benign/unspecified neoplasm related to pregnancy
Injury complicating pregnancy
Congenital anomaly complicating pregnancy
Pregnancy
Unwanted pregnancy
Ectopic pregnancy
Toxaemia of pregnancy
Abortion spontaneous
Abortion induced
Pregnancy high risk
Gestational diabetes
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ICPC Code
W90
W91
W92
W93
W94
W95
W96
W99
X70
X71
X72
X73
X74
X75
X76
X77
X78
X79
X80
X81
X82
X83
X84
X85
X86
X87
X88
X89
X90
X91
X92
X99
Y70
Y71
Y72
Y73
Y74
Y75
Y76
Y77

ICPC Code Description
Uncomplicated labour/delivery livebirth
Uncomplicated labour/delivery stillbirth
Complicated labour/delivery livebirth
Complicated labour/delivery stillbirth
Puerperal mastitis
Breast disorder in pregnancy/puerperium other
Complications of puerperium other
Disorder of pregnancy/delivery other
Syphilis female
Gonorrhoea female
Genital candidiasis female
Genital trichomoniasis female
Pelvic inflammatory disease
Malignant neoplasm cervix
Malignant neoplasm breast female
Malignant neoplasm genital female other
Fibromyoma uterus
Benign neoplasm breast female
Benign neoplasm female genital
Genital neoplasm female other/unspecified
Injury genital female
Congenital anomaly genital female
Vaginitis/vulvitis NOS
Cervical disease NOS
Abnormal cervix smear
Uterovaginal prolapse
Fibrocystic disease breast
Premenstrual tension syndrome
Genital herpes female
Condylomata acuminata female
Chlamydia infection genital female
Genital disease female other
Syphilis male
Gonorrhoea male
Genital herpes male
Prostatitis/seminal vesiculitis
Orchitis/epididymitis
Balanitis
Condylomata acuminata male
Malignant neoplasm prostate
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ICPC Code
Y78
Y79
Y80
Y81
Y82
Y83
Y84
Y85
Y86
Y99

ICPC Code Description
Malignant neoplasm male genital other
Benign/unspecified neoplasm male genital
Injury male genital
Phimosis/redundant prepuce
Hypospadias
Undescended testicle
Congenital genital anomaly male other
Benign prostatic hypertrophy
Hydrocoele
Genital disease male other
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Appendix D: Referral Categories (35 Categories)

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Allergy
Anesthesiology
Cardiac Surgery
Cardiology
Cardiovascular and Thoracic Surgery
Dermatology
Emergency Medicine
Endocrinology
Otolaryngology
Gastroenterology
General Practice*
General Surgery
Genetics
Geriatrics
Haematology
Hospital/Specialty Clinic*
Internal Medicine
Microbiology/Infectious Diseases

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Nephrology
Neurosurgery
Neurology
Nuclear Medicine
Obstetrics and Gynecology
Oncology
Ophthalmology
Orthopedic Surgery
Other Services/Unknown*
Physical Medicine and
Rehabilitation
Plastic Surgery
Psychiatry
Radiation Oncology
Radiology
Respirology
Rheumatology
Urology

*Indicates referral category not originally included in the OHIP medical specialty list
Adapted From: Ontario Health Insurance Plan. Health care provider specialty codes.
http://www.health.gov.on.ca/English/providers/pub/ohip/tech_specific/pdf/5_7.pdf. Accessed
January 25, 2012.
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Appendix E: Example Data Entries of the Laboratory Tests and Investigations Variable
Laboratory Tests Data Entries
Alkaline Phosphatase
Bilirubin
Blood Film Exam
CBC*
Chloride
C-reactive protein
Creatinine
Fecal Occult Blood
Ferritin
Free T4
Glucose Random
Glycosylated Hb (HbA1C)
HDL
Hematocrit
Hemoglobin
LDL
Lipid Assessment*
Mononucleosis Screen
Platelets
Potassium
RBC count
Sedimentation Rate
Sodium
Sputum
Stool Culture
Transferrin Saturation
Triglycerides
Uric Acid
Urinalysis*
Urinalysis (Chemical)
Vitamin B12
W.B.C. Count

Investigations Data Entries
Abdomen
Ankle
Barium Enema
Bone Density
Bone Scan
Breast
Cervical Spine
Chest
CT Head
ECG
EEG
EKG
Electrocardiogram
Exercise Stress Test
Femur
Hand
Hip
Kidney
Knee
Lumbar Spine
Mammogram
MRI
Obstetrical
Pelvis
Prostate
Pulmonary Function Test
Renal
Shoulder
Sinuses
Sleep Study
Stress Test
Thorax
Thyroid
UGI
Ultrasound

*Indicates data entries that received a multiplicative factor
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Appendix F: Previous and Co-Occurring Chronic Morbidities
ICPC Code
A70
A79
A90
B72
B73
B74
B78
B81
B82
B83
B90
D74
D75
D76
D77
D84
D85
D86
D92
D93
D94
D97
D98
F83
F84
F92
F93
F94
H82
H84
H86
K73
K74
K75
K76
K77
K78
K79
K80
K81

ICPC Code Description

Tuberculosis
Malignancy NOS
Congenital anomaly NOS/multiple
Hodgkin's disease/lymphoma
Leukaemia
Malignant neoplasm blood other
Hereditary haemolytic anaemia
Anaemia vit B12/folate deficiency
Anaemia other/unspecified
Purpura/coagulation defect
HIV-infection/AIDS
Malignant neoplasm stomach
Malignant neoplasm colon/rectum
Malignant neoplasm pancreas
Malignant digestive neoplasm other/NOS
Oesophagus disease
Duodenal ulcer
Peptic ulcer other
Diverticular disease
Irritable bowel syndrome
Chronic enteritis/ulcerative colitis
Liver disease NOS
Cholecystitis/cholelithiasis
Retinopathy
Macular degeneration
Cataract
Glaucoma
Blindness
Vertiginous syndrome
Presbyacusis
Deafness
Congenital anomaly cardiovascular
Ischaemic heart disease with angina
Acute myocardial infarction
Ischaemic heart disease without angina
Heart failure
Atrial fibrillation/flutter
Paroxysmal tachycardia
Cardiac arrhythmia NOS
Heart/arterial murmur NOS
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ICPC Code
K82
K83
K84
K86
K87
K88
K89
K90
K91
K92
K93
K94
K95
L71
L83
L84
L85
L86
L88
L89
L90
L91
L92
L93
L95
N73
N74
N75
N76
N85
N86
N87
N88
N89
N90
N92
N93
N94
P15
P70
P71
P72

ICPC Code Description
Pulmonary heart disease
Heart valve disease NOS
Heart disease other
Hypertension uncomplicated
Hypertension complicated
Postural hypotension
Transient cerebral ischaemia
Stroke/cerebrovascular accident
Cerebrovascular disease
Atherosclerosis/peripheral vascular disease
Pulmonary embolism
Phlebitis/thrombophlebitis
Varicose veins of leg
Malignant neoplasm musculoskeletal
Neck syndrome
Back syndrome without radiating pain
Acquired deformity of spine
Back syndrome with radiating pain
Rheumatoid/seropositive arthritis
Osteoarthritis of hip
Osteoarthritis of knee
Osteoarthritis other
Shoulder syndrome
Tennis elbow
Osteoporosis
Neurological infection other
Malignant neoplasm nervous system
Benign neoplasm nervous system
Neoplasm nervous system unspecified
Congenital anomaly neurological
Multiple sclerosis
Parkinsonism
Epilepsy
Migraine
Cluster headache
Trigeminal neuralgia
Carpal tunnel syndrome
Peripheral neuritis/neuropathy
Chronic alcohol abuse
Dementia
Organic psychosis other
Schizophrenia
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ICPC Code
P73
P74
P75
P76
P78
P79
P80
P81
P82
P85
P86
P98
R84
R85
R90
R95
R96
S77
S86
S87
S91
T71
T81
T82
T83
T85
T86
T89
T90
T92
T93
U75
U76
U77
U88
W15
W72
X74
X75
X76
X77
Y77

ICPC Code Description
Affective psychosis
Anxiety disorder/anxiety state
Somatization disorder
Depressive disorder
Neuraesthenia/surmenage
Phobia/compulsive disorder
Personality disorder
Hyperkinetic disorder
Post-traumatic stress disorder
Mental retardation
Anorexia nervosa/bulimia
Psychosis NOS/other
Malignant neoplasm bronchus/lung
Malignant neoplasm respiratory other
Hypertrophy tonsils/adenoids
Chronic obstructive pulmonary disease
Asthma
Malignant neoplasm of skin
Dermatitis seborrhoeic
Dermatitis/atopic eczema
Psoriasis
Malignant neoplasm thyroid
Goitre
Obesity
Overweight
Hyperthyroidism/thyrotoxicosis
Hypothyroidism/myxoedema
Diabetes insulin dependent
Diabetes non-insulin dependent
Gout
Lipid disorder
Malignant neoplasm of kidney
Malignant neoplasm of bladder
Malignant neoplasm urinary other
Glomerulonephritis/nephrosis
Infertility/subfertility female
Malignant neoplasm related to pregnancy
Pelvic inflammatory disease
Malignant neoplasm cervix
Malignant neoplasm breast female
Malignant neoplasm genital female other
Malignant neoplasm prostate
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ICPC Code
Y78
Y85

ICPC Code Description
Malignant neoplasm male genital other
Benign prostatic hypertrophy
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Appendix G: Previous and Co-Occurring Psychosocial Morbidities
ICPC Code
Psychological
P01
P02
P03
P04
P05
P06
P07
P08
P09
P10
P11
P12
P13
P15
P16
P17
P18
P19
P20
P22
P23
P24
P25
P28
P29
P70
P71
P72
P73
P74
P75
P76
P77
P78
P79
P80
P81
P82
P85

ICPC Code Description
Feeling anxious/nervous/tense
Acute stress reaction
Feeling depressed
Feeling/behaving irritable/angry
Senility, feeling/behaving old
Sleep disturbance
Sexual desire reduced
Sexual fulfillment reduced
Sexual preference concern
Stammering/stuttering/tic
Eating problem in child
Bedwetting/enuresis
Encopresis/bowel training problem
Chronic alcohol abuse
Acute alcohol abuse
Tobacco abuse
Medication abuse
Drug abuse
Memory disturbance
Child behaviour symptom/complaint
Adolescent behaviour symptom/complaint
Specific learning problem
Phase of life problem adult
Limited function/disability (P)
Psychological symptom/complaint other
Dementia
Organic psychosis other
Schizophrenia
Affective psychosis
Anxiety disorder/anxiety state
Somatization disorder
Depressive disorder
Suicide/suicide attempt
Neuraesthenia/surmenage
Phobia/compulsive disorder
Personality disorder
Hyperkinetic disorder
Post-traumatic stress disorder
Mental retardation

153
ICPC Code
P86
P98
P99
Social Problems
Z01
Z02
Z03
Z04
Z05
Z06
Z07
Z08
Z09
Z10
Z11
Z12
Z13
Z14
Z15
Z16
Z18
Z19
Z20
Z21
Z22
Z23
Z24
Z25
Z28
Z29
Fear and Concern
A13
A18
A25
A26
A27
B25
B26
B27

ICPC Code Description
Anorexia nervosa/bulimia
Psychosis NOS/other
Psychological disorders other
Poverty/financial problem
Food/water problem
Housing/neighbourhood problem
Social cultural problem
Work problem
Unemployment problem
Education problem
Social welfare problem
Legal problem
Health care system problem
Compliance/being ill problem
Relationship problem with partner
Partner behaviour problem
Partner illness problem
Loss/death of partner problem
Relationship problem with child
Illness problem with child
Loss/death of child problem
Relationship problem parent/family
Behaviour problem parent/family
Illness problem parent/family
Loss/death of parent/family member problem
Relationship problem friend
Assault/harmful event problem
Limited function/disability (Z)
Social problem NOS
Concern about/fear of medical treatment
Concern about appearance
Fear of death/dying
Fear of cancer NOS
Fear of other disease NOS
Fear of AIDS/HIV
Fear of cancer blood/lymph
Fear of blood/lymph disease other
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ICPC Code
D26
D27
F27
H15
H27
K24
K25
K27
L26
L27
N26
N27
P27
R26
R27
S26
S27
T26
T27
U26
U27
W02
W21
W27
X22
X23
X24
X25
X26
X27
Y24
Y25
Y26
Y27
Z27

ICPC Code Description
Fear of cancer of digestive system
Fear of digestive disease other
Fear of eye disease
Concern with appearance of ears
Fear of ear disease
Fear of heart disease
Fear of hypertension
Fear of cardiovascular disease
Fear of cancer musculoskeletal
Fear of musculoskeletal disease other
Fear of cancer of neurological system
Fear of neurological disease other
Fear of mental disorder
Fear of cancer of respiratory system
Fear of respiratory disease other
Fear of cancer of skin
Fear of skin disease other
Fear of cancer of endocrine system
Fear of endocrine/metabolic disease other
Fear of cancer of urinary system
Fear of urinary disease other
Fear of pregnancy
Concern about body image related to pregnancy
Fear of complications of pregnancy
Concern about breast appearance female
Fear of sexually transmitted disease female
Fear of sexual dysfunction female
Fear of genital cancer female
Fear of breast cancer female
Fear of genital/breast disease female other
Fear of sexual dysfunction male
Fear of sexually transmitted disease male
Fear of genital cancer male
Fear of genital disease male other
Fear of social problem
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Appendix H: Previous and Co-Occurring Other Morbidities
ICPC Code
A01
A02
A03
A05
A06
A08
A09
A10
A11
A16
A20
A21
A23
A28
A29
A71
A72
A73
A74
A75
A76
A77
A78
A80
A81
A82
A84
A85
A86
A87
A88
A89
A91
A92
A93
A94
A95
A99
B02
B04

ICPC Code Description
Pain general/multiple sites
Chills
Fever
Feeling ill
Fainting/syncope
Swelling
Sweating problem
Bleeding/haemorrhage NOS
Chest pain NOS
Irritable infant
Euthanasia request/discussion
Risk factor for malignancy
Risk factor NOS
Limited function/disability NOS
General symptom/complaint other
Measles
Chickenpox
Malaria
Rubella
Infectious mononucleosis
Viral exanthem other
Viral disease other/NOS
Malignancy NOS
Trauma/injury NOS
Multiple trauma/injuries
Secondary effect of trauma
Poisoning by medical agent
Adverse effect medical agent
Toxic effect non-medicinal substance
Complication of medical treatment
Adverse effect physical factor
Effect prosthetic device
Abnormal result investigation NOS
Allergy/allergic reaction NOS
Premature newborn
Perinatal morbidity other
Perinatal mortality
Disease/condition of unspecified nature/site
Lymph gland(s) enlarged/painful
Blood symptom/complaint
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ICPC Code
B28
B29
B70
B71
B75
B76
B77
B79
B80
B84
B87
B99
D01
D02
D03
D04
D05
D06
D07
D08
D09
D10
D11
D12
D13
D14
D15
D16
D17
D18
D19
D20
D21
D23
D24
D25
D28
D29
D70
D71
D72
D73

ICPC Code Description
Limited function/disability (B)
Lymph/immune mechanism symptom/complaint other
Lymphadenitis acute
Lymphadenitis chronic/non-specific
Neoplasm blood benign/unspecified
Ruptured spleen traumatic
Injury blood/lymph/spleen other
Congenital anomaly blood/lymph other
Iron deficiency anaemia
Unexplained abnormal white cells
Splenomegaly
Blood/lymph/spleen disease other
Abdominal pain/cramps general
Abdominal pain epigastric
Heartburn
Rectal/anal pain
Perianal itching
Abdominal pain localized other
Dyspepsia/indigestion
Flatulence/gas/belching
Nausea
Vomiting
Diarrhoea
Constipation
Jaundice
Haematemesis/vomiting blood
Melaena
Rectal bleeding
Incontinence of bowel
Change in faeces/bowel movements
Teeth/gum symptom/complaint
Mouth/tongue/lip symptom/complaint
Swallowing problem
Hepatomegaly
Abdominal mass NOS
Abdominal distension
Limited function/disability (D)
Digestive symptom/complaint other
Gastrointestinal infection
Mumps
Viral hepatitis
Gastroenteritis presumed infection
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ICPC Code
D78
D79
D80
D81
D82
D83
D87
D88
D89
D90
D91
D95
D96
D99
F01
F02
F03
F04
F05
F13
F14
F15
F16
F17
F18
F28
F29
F70
F71
F72
F73
F74
F75
F76
F79
F80
F81
F82
F85
F86
F91
F95

ICPC Code Description
Neoplasm digestive system benign/unspecified
Foreign body digestive system
Injury digestive system other
Congenital anomaly digestive system
Teeth/gum disease
Mouth/tongue/lip disease
Stomach function disorder
Appendicitis
Inguinal hernia
Hiatus hernia
Abdominal hernia other
Anal fissure/perianal abscess
Worms/other parasites
Disease digestive system other
Eye pain
Red eye
Eye discharge
Visual floaters/spots
Visual disturbance other
Eye sensation abnormal
Eye movements abnormal
Eye appearance abnormal
Eyelid symptom/complaint
Glasses symptom/complaint
Contact lens symptom/complaint
Limited function/disability (F)
Eye symptom/complaint other
Conjunctivitis infectious
Conjunctivitis allergic
Blepharitis/stye/chalazion
Eye infection/inflammation other
Neoplasm of eye/adnexa
Contusion/haemorrhage eye
Foreign body in eye
Injury eye other
Blocked lacrimal duct of infant
Congenital anomaly eye other
Detached retina
Corneal ulcer
Trachoma
Refractive error
Strabismus
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ICPC Code
F99
H01
H02
H03
H04
H05
H13
H28
H29
H70
H71
H72
H73
H74
H75
H76
H77
H78
H79
H80
H81
H83
H85
H99
K01
K02
K03
K04
K05
K06
K07
K22
K28
K29
K70
K71
K72
K85
K96
K99
L01
L02

ICPC Code Description
Eye/adnexa disease other
Ear pain/earache
Hearing complaint
Tinnitus, ringing/buzzing ear
Ear discharge
Bleeding ear
Plugged feeling ear
Limited function/disability (H)
Ear symptom/complaint other
Otitis externa
Acute otitis media/myringitis
Serous otitis media
Eustachian salpingitis
Chronic otitis media
Neoplasm of ear
Foreign body in ear
Perforation ear drum
Superficial injury of ear
Ear injury other
Congenital anomaly of ear
Excessive ear wax
Otosclerosis
Acoustic trauma
Ear/mastoid disease other
Heart pain
Pressure/tightness of heart
Cardiovascular pain NOS
Palpitations/awareness of heart
Irregular heartbeat other
Prominent veins
Swollen ankles/oedema
Risk factor for cardiovascular disease
Limited function/disability (K)
Cardiovascular symptom/complaint other
Infection of circulatory system
Rheumatic fever/heart disease
Neoplasm cardiovascular
Elevated blood pressure
Haemorrhoids
Cardiovascular disease other
Neck symptom/complaint
Back symptom/complaint
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ICPC Code
L03
L04
L05
L07
L08
L09
L10
L11
L12
L13
L14
L15
L16
L17
L18
L19
L20
L28
L29
L70
L72
L73
L74
L75
L76
L77
L78
L79
L80
L81
L82
L87
L94
L96
L97
L98
L99
N01
N03
N04
N05
N06

ICPC Code Description
Low back symptom/complaint
Chest symptom/complaint
Flank/axilla symptom/complaint
Jaw symptom/complaint
Shoulder symptom/complaint
Arm symptom/complaint
Elbow symptom/complaint
Wrist symptom/complaint
Hand/finger symptom/complaint
Hip symptom/complaint
Leg/thigh symptom/complaint
Knee symptom/complaint
Ankle symptom/complaint
Foot/toe symptom/complaint
Muscle pain
Muscle symptom/complaint NOS
Joint symptom/complaint NOS
Limited function/disability (L)
Musculoskeletal symptom/complaint other
Infection of musculoskeletal system
Fracture: radius/ulna
Fracture: tibia/fibula
Fracture: hand/foot bone
Fracture: femur
Fracture: other
Sprain/strain of ankle
Sprain/strain of knee
Sprain/strain of joint NOS
Dislocation/subluxation
Injury musculoskeletal NOS
Congenital anomaly musculoskeletal
Bursitis/tendinitis/synovitis NOS
Osteochondrosis
Acute internal damage knee
Neoplasm musculoskeletal benign/unspecified
Acquired deformity of limb
Musculoskeletal disease other
Headache
Pain face
Restless legs
Tingling fingers/feet/toes
Sensation disturbance other
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ICPC Code
N07
N08
N16
N17
N18
N19
N28
N29
N70
N71
N72
N79
N80
N81
N91
N95
N99
R01
R02
R03
R04
R05
R06
R07
R08
R09
R21
R23
R24
R25
R28
R29
R71
R72
R73
R74
R75
R76
R77
R78
R79
R80

ICPC Code Description
Convulsion/seizure
Abnormal involuntary movements
Disturbance of smell/taste
Vertigo/dizziness
Paralysis/weakness
Speech disorder
Limited function/disability (N)
Neurological symptom/complaint other
Poliomyelitis
Meningitis/encephalitis
Tetanus
Concussion
Head injury other
Injury nervous system other
Facial paralysis/bell's palsy
Tension headache
Neurological disease other
Pain respiratory system
Shortness of breath/dyspnoea
Wheezing
Breathing problem other
Cough
Nose bleed/epistaxis
Sneezing/nasal congestion
Nose symptom/complaint other
Sinus symptom/complaint
Throat symptom/complaint
Voice symptom/complaint
Haemoptysis
Sputum/phlegm abnormal
Limited function/disability (R )
Respiratory symptom/complaint other
Whooping cough
Strep throat
Boil/abscess nose
Upper respiratory infection acute
Sinusitis acute/chronic
Tonsillitus acute
Laryngitis/tracheitis acute
Acute bronchitis/bronchiolitis
Chronic bronchitis
Influenza
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ICPC Code
R81
R82
R83
R86
R87
R88
R89
R92
R97
R98
R99
S01
S02
S03
S04
S05
S06
S07
S08
S09
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21
S22
S23
S24
S28
S29
S70
S71
S72
S73
S74

ICPC Code Description
Pneumonia
Pleurisy/pleural effusion
Respiratory infection other
Benign neoplasm respiratory
Foreign body nose/larynx/bronchus
Injury respiratory other
Congenital anomaly respiratory
Neoplasm respiratory unspecified
Allergic rhinitis
Hyperventilation syndrome
Respiratory disease other
Pain/tenderness of skin
Pruritus
Warts
Lump/swelling localized
Lumps/swellings generalized
Rash localized
Rash generalized
Skin colour change
Infected finger/toe
Boil/carbuncle
Skin infection post-traumatic
Insect bite/sting
Animal/human bite
Burn/scald
Foreign body in skin
Bruise/contusion
Abrasion/scratch/blister
Laceration/cut
Skin injury other
Corn/callosity
Skin texture symptom/complaint
Nail symptom/complaint
Hair loss/baldness
Hair/scalp symptom/complaint other
Limited function/disability (S)
Skin symptom/complaint other
Herpes zoster
Herpes simplex
Scabies/other acariasis
Pediculosis/skin infestation other
Dermatophytosis
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ICPC Code
S75
S76
S78
S79
S80
S81
S82
S83
S84
S85
S88
S89
S90
S92
S93
S94
S95
S96
S97
S98
S99
T01
T02
T03
T04
T05
T07
T08
T10
T11
T28
T29
T70
T72
T73
T78
T80
T87
T91
T99
U01
U02

ICPC Code Description
Moniliasis/candidiasis skin
Skin infection other
Lipoma
Neoplasm skin benign/unspecified
Solar keratosis/sunburn
Haemangioma/lymphangioma
Naevus/mole
Congenital skin anomaly other
Impetigo
Pilonidal cyst/fistula
Dermatitis contact/allergic
Diaper rash
Pityriasis rosea
Sweat gland disease
Sebaceous cyst
Ingrown nail
Molluscum contagiosum
Acne
Chronic ulcer skin
Urticaria
Skin disease other
Excessive thirst
Excessive appetite
Loss of appetite
Feeding problem of infant/child
Feeding problem of adult
Weight gain
Weight loss
Growth delay
Dehydration
Limited function/disability (T)
Endocrine/metabolic/nutritional symptom/complaint other
Endocrine infection
Benign neoplasm thyroid
Neoplasm endocrine other/unspecified
Thyroglossal duct/cyst
Congenital anomaly endocrine/metabolic
Hypoglycaemia
Vitamin/nutritional deficiency
Endocrine/metabolic/nutritional disease other
Dysuria/painful urination
Urinary frequency/urgency
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ICPC Code
U04
U05
U06
U07
U08
U13
U14
U28
U29
U70
U71
U72
U78
U79
U80
U85
U90
U95
U98
U99
W01
W03
W05
W10
W11
W12
W13
W14
W17
W18
W19
W28
W29
W70
W71
W73
W75
W76
W78
W79
W80
W81

ICPC Code Description
Incontinence urine
Urination problems other
Haematuria
Urine symptom/complaint other
Urinary retention
Bladder symptom/complaint other
Kidney symptom/complaint
Limited function/disability (U)
Urinary symptom/complaint other
Pyelonephritis/pyelitis
Cystitis/urinary infection other
Urethritis
Benign neoplasm urinary tract
Neoplasm urinary tract unspecified
Injury urinary tract
Congenital anomaly urinary tract
Orthostatic albuminuria/proteinuria
Urinary calculus
Abnormal urine test NOS
Urinary disease other
Question of pregnancy
Antepartum bleeding
Pregnancy vomiting/nausea
Contraception postcoital
Contraception oral
Contraception intrauterine
Sterilization female
Contraception female other
Post-partum bleeding
Post-partum symptom/complaint other
Breast/lactation symptom/complaint
Limited function/disability (W)
Pregnancy symptom/complaint other
Puerperal infection/sepsis
Other infection complicating pregnancy/puerperium
Benign/unspecified neoplasm related to pregnancy
Injury complicating pregnancy
Congenital anomaly complicating pregnancy
Pregnancy
Unwanted pregnancy
Ectopic pregnancy
Toxaemia of pregnancy
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ICPC Code
W82
W83
W84
W85
W90
W91
W92
W93
W94
W95
W96
W99
X01
X02
X03
X04
X05
X06
X07
X08
X09
X10
X11
X12
X13
X14
X15
X16
X17
X18
X19
X20
X21
X28
X29
X70
X71
X72
X73
X78
X79
X80

ICPC Code Description
Abortion spontaneous
Abortion induced
Pregnancy high risk
Gestational diabetes
Uncomplicated labour/delivery livebirth
Uncomplicated labour/delivery stillbirth
Complicated labour/delivery livebirth
Complicated labour/delivery stillbirth
Puerperal mastitis
Breast disorder in pregnancy/puerperium other
Complications of puerperium other
Disorder of pregnancy/delivery other
Genital pain female
Menstrual pain
Intermenstrual pain
Painful intercourse female
Menstruation absent/scanty
Menstruation excessive
Menstruation irregular/frequent
Intermenstrual bleeding
Premenstrual symptom/complaint
Postponement of menstruation
Menopausal symptom/complaint
Postmenopausal bleeding
Postcoital bleeding
Vaginal discharge
Vaginal symptom/complaint other
Vulval symptom/complaint
Pelvis symptom/complaint female
Breast pain female
Breast lump/mass female
Nipple symptom/complaint female
Breast symptom/complaint female other
Limited function/disability (X)
Genital symptom/complaint female other
Syphilis female
Gonorrhoea female
Genital candidiasis female
Genital trichomoniasis female
Fibromyoma uterus
Benign neoplasm breast female
Benign neoplasm female genital
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ICPC Code
X81
X82
X83
X84
X85
X86
X87
X88
X89
X90
X91
X92
X99
Y01
Y02
Y03
Y04
Y05
Y06
Y07
Y08
Y10
Y13
Y14
Y16
Y28
Y29
Y70
Y71
Y72
Y73
Y74
Y75
Y76
Y79
Y80
Y81
Y82
Y83
Y84
Y86
Y99

ICPC Code Description
Genital neoplasm female other/unspecified
Injury genital female
Congenital anomaly genital female
Vaginitis/vulvitis NOS
Cervical disease NOS
Abnormal cervix smear
Uterovaginal prolapse
Fibrocystic disease breast
Premenstrual tension syndrome
Genital herpes female
Condylomata acuminata female
Chlamydia infection genital female
Genital disease female other
Pain in penis
Pain in testis/scrotum
Urethral discharge male
Penis symptom/complaint other
Scrotum/testis symptom/complaint other
Prostate symptom/complaint
Impotence NOS
Sexual function symptom/complaint male
Infertility/subfertility male
Sterilization male
Family planning male other
Breast symptom/complaint male
Limited function/disability (Y)
Genital symptom/complaint male other
Syphilis male
Gonorrhoea male
Genital herpes male
Prostatitis/seminal vesiculitis
Orchitis/epididymitis
Balanitis
Condylomata acuminata male
Benign/unspecified neoplasm male genital
Injury male genital
Phimosis/redundant prepuce
Hypospadias
Undescended testicle
Congenital genital anomaly male other
Hydrocoele
Genital disease male other
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Appendix I: Run-In and Follow-Up Period Sensitivity Analysis for Number of Subsequent
Visits
Length of Run-In and Follow-Up Period of
ICPC Coding
Characteristic

Six Month Run-In and
Follow-Up Period of
ICPC Coding (N=167)

One Year Run-In and
Follow-Up Period of
ICPC Coding (N=103)

Previous Care-Seeking Frequency

+

+

Number of Laboratory Tests and
Investigations

+

+

Age
Female
Number of Previous and Co-Occurring
Chronic Morbidities
Number of Previous and Co-Occurring
Psychosocial Morbidities
Number of Previous and Co-Occurring
Other Morbidities

NOTE:
+ Indicates a statistically significant positive relationship
− Indicates a statistically significant negative relationship
An empty box indicates no statistically significant relationship in the multivariable analysis or
p>0.2 in bivariate analysis
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Appendix J: Run-In and Follow-Up Period Sensitivity Analysis for Number of Referrals
Length of Run-In and Follow-Up Period of
ICPC Coding
Characteristic

Six Month Run-In and
Follow-Up Period of
ICPC Coding (N=167)

One Year Run-In and
Follow-Up Period of
ICPC Coding (N=103)

−

−

Number of Previous and Co-Occurring
Other Morbidities

+

+

Previous Care-Seeking Frequency

−

−

Age
Female
Number of Previous and Co-Occurring
Chronic Morbidities
Number of Previous and Co-Occurring
Psychosocial Morbidities

NOTE:
+ Indicates a statistically significant positive relationship
− Indicates a statistically significant negative relationship
An empty box indicates no statistically significant relationship in the multivariable analysis or
p>0.2 in bivariate analysis
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Appendix K: Run-In and Follow-Up Period Sensitivity Analysis for Number of Laboratory
Tests and Investigations
Length of Run-In and Follow-Up Period of
ICPC Coding
Characteristic

Six Month Run-In and
Follow-Up Period of
ICPC Coding (N=167)

One Year Run-In and
Follow-Up Period of
ICPC Coding (N=103)

Age
Female

−

Number of Previous and Co-Occurring
Chronic Morbidities
Number of Previous and Co-Occurring
Psychosocial Morbidities
Number of Previous and Co-Occurring
Other Morbidities
Previous Care-Seeking Frequency

−

−

Number of Subsequent Visits

+

+

NOTE:
+ Indicates a statistically significant positive relationship
− Indicates a statistically significant negative relationship
An empty box indicates no statistically significant relationship in the multivariable analysis or
p>0.2 in bivariate analysis
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Appendix L: Comparison of Included and Excluded Fatigue Symptom Patients
Included Patients
N=103 (37.6%)

Excluded Patients
N=171 (62.4%)

p-value1

63.1

63.3

0.304

Female

70 (68%)

112 (63%)

0.430

Male

33 (32%)

65 (37%)

Characteristic
Mean Age (years)
Sex, n (%)

1

Results from two-sample t-tests
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Appendix M: Comparison of the DELPHI ICPC Patient Population (N=3,341) and the
2011 Canadian Census Population (N=33,476,685)
Canadian Census Population
N=33,476,6852

DELPHI ICPC Population
N=3,3411

Median Age

39.5

56.0

Median Age of Males

38.6

57.0

Median Age of Females

40.4

55.0

Males

49%

43%

Females

51%

57%

Characteristic
Age Distribution (years)

Sex Distribution

Note:
1
Sample of patients coded using the International Classification of Primary Care (ICPC), derived
from the Deliver Primary Health Care Information (DELPHI) Project.
2
2011 Canadian Census Population data derived from: Statistics Canada. 2011 Census of
Population. Statistics Canada Catalogue. Ottawa: Catalogue No.: 98-316-XWE.
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